[
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT03309007",
                "orgStudyIdInfo": {
                    "id": "17-214"
                },
                "organization": {
                    "fullName": "University of New Mexico",
                    "class": "OTHER"
                },
                "briefTitle": "A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes",
                "officialTitle": "A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes"
            },
            "statusModule": {
                "statusVerifiedDate": "2023-12",
                "overallStatus": "COMPLETED",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2017-09-01",
                    "type": "ACTUAL"
                },
                "primaryCompletionDateStruct": {
                    "date": "2020-08-20",
                    "type": "ACTUAL"
                },
                "completionDateStruct": {
                    "date": "2020-08-20",
                    "type": "ACTUAL"
                },
                "studyFirstSubmitDate": "2017-07-07",
                "studyFirstSubmitQcDate": "2017-10-11",
                "studyFirstPostDateStruct": {
                    "date": "2017-10-13",
                    "type": "ACTUAL"
                },
                "resultsFirstSubmitDate": "2023-08-11",
                "resultsFirstSubmitQcDate": "2023-12-07",
                "resultsFirstPostDateStruct": {
                    "date": "2023-12-11",
                    "type": "ACTUAL"
                },
                "lastUpdateSubmitDate": "2023-12-07",
                "lastUpdatePostDateStruct": {
                    "date": "2023-12-11",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "University of New Mexico",
                    "class": "OTHER"
                }
            },
            "oversightModule": {
                "oversightHasDmc": false,
                "isFdaRegulatedDrug": true,
                "isFdaRegulatedDevice": false
            },
            "descriptionModule": {
                "briefSummary": "The goal of this pilot and feasibility study is to investigate the effects of a short course of metformin therapy on a surrogate marker of cellular senescence and autophagy among adult patients with prediabetes. The overall hypothesis is that metformin will have beneficial effects on longevity and quality of life by inducing autophagy downstream of activating adenosine monophosphate-activated protein kinase (AMPK) and inhibiting mechanistic target of rapamycin (mTOR) through potential effects of reduced inflammation, reduced degeneration of muscle and tendon tissue, antineoplastic effects, reduced obesity and hyperglycemia, preserved cardiovascular functions, and/or the prevention of neurodegeneration (such as age-associated dementia). This pilot study will address the following aim:\n\nDemonstrate that metformin therapy will increase cellular autophagy as an inverse correlate of aging as measured by increases in Microtubule-associated protein 1A/1B-light chain 3 (LC3) scores.\n\nHypothesis 1: In addition to beneficial effects on glycemia, body weight, and body composition, metformin therapy exerts beneficial effects on surrogate measures of autophagy and aging.\n\nPrimary outcome: Increased levels of LC3 in leukocytes.",
                "detailedDescription": "Anti-aging medicine is a burgeoning field. Accumulating evidence implicates the cellular process of autophagy as a primary mechanism of normal aging and the diseases associated with it. Autophagy is a process of \"cellular recycling\" and is known to affect a spectrum of health and disease states associated with aging, including inflammatory disorders, metabolic syndrome, type 2 diabetes, cardiovascular disease, cancer, and neurodegeneration. The dynamics of autophagy are controlled by autophagy-related genes and by one of the central regulators of metabolism, AMPK (the target of metformin). Autophagy also affects stem cells and cellular senescence. When the process of autophagy fails, the result is a state of chronic inflammation and degeneration in many organ systems.\n\nNumerous studies have documented the metabolic benefits conferred by the glucose lowering agent metformin. In animal models, metformin has been shown to increase both lifespan and health-span, and a clinical trial (NCT02432287) is currently ongoing to determine whether this effect translates to humans, with additional investigation into how the medication alters the adult human transcriptome. In vitro studies demonstrate metformin's ability to mitigate aging- and disease-related inflammation, oxidative damage, and diminished autophagy. Additionally, there are numerous cohort, case-control and meta-analysis studies confirming metformin's reduction in cancer-related death via hypothesized activity in the relevant mTOR, human epidermal growth factor receptor 2 (HER2), micro-Ribosomal Nucleic Acid (miRNA) and transcription growth factor alpha (TGF-alpha) pathways and processes. As such, the National Institutes of Health (NIH) has issued an Funding Opportunity Announcement (FOA) parent announcement PA-17-073 (https://grants.nih.gov/grants/guide/pa-files/PA-17-073.html) to solicit additional clinical studies that will evaluate metformin's effects on aging and age-related conditions.\n\nThe long term goal of this study is to develop a Phase III study in response to this FOA using leucocyte LC3, transcription factor EB (TFEB) scores, total DNA methylation and galectin-3 to gauge the magnitude of metformin's effects on autophagy and cellular senescence as proxies for aging in adults with prediabetes. This study will provide preliminary data for such a proposal, and it will fill a knowledge gap regarding the use of validated biomarkers in this arena. It will also contribute significantly to the anti-aging literature. The primary objective of this proposal is to validate the autophagy-related experimental design by using leucocyte LC3 as a marker of autophagy and cellular senescence in humans.\n\nAim: Demonstrate that metformin therapy will increase cellular autophagy as an inverse correlate of aging as measured by increases in LC3 scores.\n\nHypothesis 1: In addition to beneficial effects on glycemia, body weight, and body composition, metformin therapy exerts beneficial effects on surrogate measures of autophagy and aging.\n\nPrimary outcome: Increased levels of LC3.\n\nFUTURE DIRECTIONS Confirmation of improvement in markers of autophagy resulting from treatment with metformin will justify the submission of grant proposals for more definitive clinical trials examining the effect of metformin on actual clinical outcomes (as opposed to surrogate measures) in pursuit of a potential Food and Drug Administration (FDA) indication for metformin as an anti-aging therapy."
            },
            "conditionsModule": {
                "conditions": [
                    "PreDiabetes",
                    "Aging"
                ],
                "keywords": [
                    "Autophagy"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE3"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "interventionModelDescription": "This is a double-blind, approximate placebo-controlled trial of 12 weeks of metformin vs. CaCO3 (Placebo) among adult patients with prediabetes.",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "QUADRUPLE",
                        "maskingDescription": "Only the study research pharmacy will have access to the randomization list.",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR",
                            "OUTCOMES_ASSESSOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 25,
                    "type": "ACTUAL"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Metformin",
                        "type": "EXPERIMENTAL",
                        "description": "Metformin started at 500 mg po twice daily (BID), and then titrated up to 1000 mg po q morning (AM) and 500 po q evening (PM) over the course of 1 month, as tolerated.",
                        "interventionNames": [
                            "Drug: Metformin"
                        ]
                    },
                    {
                        "label": "Placebo Oral Tablet",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "Near-identical CaCO3 as a Placebo Oral Tablet will be started at 648 mg po BID, and then titrated up to 1296 mg po q AM and 648 mg po q PM over the course of 1 month, as tolerated.",
                        "interventionNames": [
                            "Drug: Placebo Oral Tablet"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Metformin",
                        "description": "Total daily dose titrated up to 1500 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks.",
                        "armGroupLabels": [
                            "Metformin"
                        ],
                        "otherNames": [
                            "Glucophage"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Placebo Oral Tablet",
                        "description": "Total daily dose titrated up to 1944 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks.",
                        "armGroupLabels": [
                            "Placebo Oral Tablet"
                        ],
                        "otherNames": [
                            "Calcium Carbonate"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Change in Leucocyte LC3 Score",
                        "description": "During the process of autophagy, autophagosomes engulf cytoplasmic components and concomitantly, the cytosolic form of LC3 (LC3-I) is conjugated to phosphatidyl ethanolamine, resulting in the autophagosomal membrane-bound form (LC3-II). LC3-II is a widely used marker to monitor autophagosome formation by quantitation of the number of LC3-labeled puncta (autophagosomes, or \"dots\") per cell detected by fluorescence microscopy. An increase in LC3 puncta formation denotes an increase in autophagic activity.",
                        "timeFrame": "Data will be collected at 0 and 12 weeks and analyzed within 8 weeks of sample collection."
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults with prediabetes (defined as an A1c of 5.7-6.4%)\n* BMI between 27 and 40 kg/m2 (inclusive).\n\nExclusion Criteria:\n\n* Prior treatment with metformin or other diabetes medications,\n* Pregnancy,\n* Significant renal dysfunction (Serum Creatinine \\> 1.3 mg/dl for women, \\> 1.4 mg/dl for men),\n* Severe hepatic dysfunction (aspartate amnotransferease \\[AST\\] or alanine aminotransferase \\[ALT\\] \\> 3 times the upper limit of normal),\n* Ongoing alcohol or substance abuse,\n* Inflammatory bowel disease,\n* Ongoing glucocorticoid therapy,\n* Or inability to render informed consent.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "30 Years",
                "maximumAge": "70 Years",
                "stdAges": [
                    "ADULT",
                    "OLDER_ADULT"
                ]
            },
            "contactsLocationsModule": {
                "overallOfficials": [
                    {
                        "name": "Mark R Burge, MD",
                        "affiliation": "Professor Medicine, UNM HSC Endocrinology",
                        "role": "PRINCIPAL_INVESTIGATOR"
                    }
                ],
                "locations": [
                    {
                        "facility": "University of New Mexico Clincal & Translational Science Center",
                        "city": "Albuquerque",
                        "state": "New Mexico",
                        "zip": "87131",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.08449,
                            "lon": -106.65114
                        }
                    }
                ]
            },
            "ipdSharingStatementModule": {
                "ipdSharing": "YES",
                "description": "De-identified data will be made available for data sharing as is consistent with current NIH guidelines.",
                "infoTypes": [
                    "STUDY_PROTOCOL",
                    "ICF"
                ],
                "timeFrame": "After the study is completed and published. The data should be available in perpetuity in the University of New Mexico (UNM) Digital Repository.",
                "accessCriteria": "No restrictions.",
                "url": "http://digitalrepository.unm.edu/"
            }
        },
        "resultsSection": {
            "participantFlowModule": {
                "groups": [
                    {
                        "id": "FG000",
                        "title": "Metformin",
                        "description": "Metformin started at 500 mg po twice daily (BID), and then titrated up to 1000 mg po q morning (AM) and 500 po q evening (PM) over the course of 1 month, as tolerated.\n\nMetformin: Total daily dose titrated up to 1500 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks."
                    },
                    {
                        "id": "FG001",
                        "title": "Placebo Oral Tablet",
                        "description": "Near-identical CaCO3 as a Placebo Oral Tablet will be started at 648 mg po BID, and then titrated up to 1296 mg po q AM and 648 mg po q PM over the course of 1 month, as tolerated.\n\nPlacebo Oral Tablet: Total daily dose titrated up to 1944 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks."
                    }
                ],
                "periods": [
                    {
                        "title": "Overall Study",
                        "milestones": [
                            {
                                "type": "STARTED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "13"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "12"
                                    }
                                ]
                            },
                            {
                                "type": "COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "13"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "12"
                                    }
                                ]
                            },
                            {
                                "type": "NOT COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "baselineCharacteristicsModule": {
                "groups": [
                    {
                        "id": "BG000",
                        "title": "Metformin",
                        "description": "Metformin 500 mg po BID titrated to 1000 q AM and 500 q PM over one month, as tolerated."
                    },
                    {
                        "id": "BG001",
                        "title": "Placebo Oral Tablet",
                        "description": "Placebo (CaCO3) 648 mg po BID titrated to 1296 qAM and 648 q PM over one month, as tolerated."
                    },
                    {
                        "id": "BG002",
                        "title": "Total",
                        "description": "Total of all reporting groups"
                    }
                ],
                "denoms": [
                    {
                        "units": "Participants",
                        "counts": [
                            {
                                "groupId": "BG000",
                                "value": "13"
                            },
                            {
                                "groupId": "BG001",
                                "value": "12"
                            },
                            {
                                "groupId": "BG002",
                                "value": "25"
                            }
                        ]
                    }
                ],
                "measures": [
                    {
                        "title": "Age, Categorical",
                        "paramType": "COUNT_OF_PARTICIPANTS",
                        "unitOfMeasure": "Participants",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "title": "<=18 years",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Between 18 and 65 years",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "10"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "5"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "15"
                                            }
                                        ]
                                    },
                                    {
                                        "title": ">=65 years",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "3"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "7"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "10"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Age, Continuous",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "years",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "59.3",
                                                "spread": "10.1"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "62.3",
                                                "spread": "7.4"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "60.8",
                                                "spread": "9"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Sex: Female, Male",
                        "paramType": "COUNT_OF_PARTICIPANTS",
                        "unitOfMeasure": "Participants",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "title": "Female",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "7"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "8"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "15"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Male",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "6"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "4"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "10"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Race (NIH/OMB)",
                        "populationDescription": "Total 25 enrolled",
                        "paramType": "COUNT_OF_PARTICIPANTS",
                        "unitOfMeasure": "Participants",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "title": "American Indian or Alaska Native",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "1"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "1"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Asian",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Native Hawaiian or Other Pacific Islander",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Black or African American",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "1"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "1"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "White",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "11"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "23"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "More than one race",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Unknown or Not Reported",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Region of Enrollment",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "United States",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "13"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "25"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "outcomeMeasuresModule": {
                "outcomeMeasures": [
                    {
                        "type": "PRIMARY",
                        "title": "Change in Leucocyte LC3 Score",
                        "description": "During the process of autophagy, autophagosomes engulf cytoplasmic components and concomitantly, the cytosolic form of LC3 (LC3-I) is conjugated to phosphatidyl ethanolamine, resulting in the autophagosomal membrane-bound form (LC3-II). LC3-II is a widely used marker to monitor autophagosome formation by quantitation of the number of LC3-labeled puncta (autophagosomes, or \"dots\") per cell detected by fluorescence microscopy. An increase in LC3 puncta formation denotes an increase in autophagic activity.",
                        "reportingStatus": "POSTED",
                        "paramType": "MEAN",
                        "dispersionType": "Standard Deviation",
                        "unitOfMeasure": "Fold Change (Arbitrary Units)",
                        "timeFrame": "Data will be collected at 0 and 12 weeks and analyzed within 8 weeks of sample collection.",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Metformin",
                                "description": "Metformin started at 500 mg po twice daily (BID), and then titrated up to 1000 mg po q morning (AM) and 500 po q evening (PM) over the course of 1 month, as tolerated.\n\nMetformin: Total daily dose titrated up to 1500 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo Oral Tablet",
                                "description": "Near-identical CaCO3 as a Placebo Oral Tablet will be started at 648 mg po BID, and then titrated up to 1296 mg po q AM and 648 mg po q PM over the course of 1 month, as tolerated.\n\nPlacebo Oral Tablet: Total daily dose titrated up to 1944 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "13"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "12"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "0.1",
                                                "spread": "3.4"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-1.8",
                                                "spread": "3.0"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "adverseEventsModule": {
                "frequencyThreshold": "4",
                "timeFrame": "12 weeks",
                "eventGroups": [
                    {
                        "id": "EG000",
                        "title": "Metformin",
                        "description": "Metformin started at 500 mg po twice daily (BID), and then titrated up to 1000 mg po q morning (AM) and 500 po q evening (PM) over the course of 1 month, as tolerated.\n\nMetformin: Total daily dose titrated up to 1500 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks.",
                        "deathsNumAffected": 0,
                        "deathsNumAtRisk": 13,
                        "seriousNumAffected": 0,
                        "seriousNumAtRisk": 13,
                        "otherNumAffected": 1,
                        "otherNumAtRisk": 13
                    },
                    {
                        "id": "EG001",
                        "title": "Placebo Oral Tablet",
                        "description": "Near-identical CaCO3 as a Placebo Oral Tablet will be started at 648 mg po BID, and then titrated up to 1296 mg po q AM and 648 mg po q PM over the course of 1 month, as tolerated.\n\nPlacebo Oral Tablet: Total daily dose titrated up to 1944 mg po q day over the course of 4 weeks and continued for a total exposure of 12 weeks.",
                        "deathsNumAffected": 0,
                        "deathsNumAtRisk": 12,
                        "seriousNumAffected": 0,
                        "seriousNumAtRisk": 12,
                        "otherNumAffected": 0,
                        "otherNumAtRisk": 12
                    }
                ],
                "otherEvents": [
                    {
                        "term": "Diarrhea",
                        "organSystem": "Gastrointestinal disorders",
                        "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numEvents": 1,
                                "numAffected": 1,
                                "numAtRisk": 13
                            },
                            {
                                "groupId": "EG001",
                                "numEvents": 0,
                                "numAffected": 0,
                                "numAtRisk": 12
                            }
                        ]
                    }
                ]
            },
            "moreInfoModule": {
                "certainAgreement": {
                    "piSponsorEmployee": false,
                    "restrictiveAgreement": false
                },
                "pointOfContact": {
                    "title": "MArk Burge",
                    "organization": "UNewMexico",
                    "email": "mburge@salud.unm.edu",
                    "phone": "5052724658"
                }
            }
        },
        "documentSection": {
            "largeDocumentModule": {
                "largeDocs": [
                    {
                        "typeAbbrev": "Prot_SAP",
                        "hasProtocol": true,
                        "hasSap": true,
                        "hasIcf": false,
                        "label": "Study Protocol and Statistical Analysis Plan",
                        "date": "2018-05-08",
                        "uploadDate": "2023-10-06T14:30",
                        "filename": "Prot_SAP_002.pdf",
                        "size": 303120
                    },
                    {
                        "typeAbbrev": "ICF",
                        "hasProtocol": false,
                        "hasSap": false,
                        "hasIcf": true,
                        "label": "Informed Consent Form",
                        "date": "2018-05-10",
                        "uploadDate": "2023-12-07T12:11",
                        "filename": "ICF_006.pdf",
                        "size": 165231
                    }
                ]
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2025-09-19",
                "submissionTracking": {
                    "firstMcpInfo": {
                        "postDateStruct": {
                            "date": "2023-09-06",
                            "type": "ACTUAL"
                        }
                    }
                }
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D011236",
                        "term": "Prediabetic State"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D009750",
                        "term": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "id": "D004700",
                        "term": "Endocrine System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "D008687",
                        "term": "Metformin"
                    },
                    {
                        "id": "D058110",
                        "term": "Counterfeit Drugs"
                    },
                    {
                        "id": "D002119",
                        "term": "Calcium Carbonate"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D001645",
                        "term": "Biguanides"
                    },
                    {
                        "id": "D006146",
                        "term": "Guanidines"
                    },
                    {
                        "id": "D000578",
                        "term": "Amidines"
                    },
                    {
                        "id": "D009930",
                        "term": "Organic Chemicals"
                    },
                    {
                        "id": "D000078742",
                        "term": "Substandard Drugs"
                    },
                    {
                        "id": "D004364",
                        "term": "Pharmaceutical Preparations"
                    },
                    {
                        "id": "D017610",
                        "term": "Calcium Compounds"
                    },
                    {
                        "id": "D007287",
                        "term": "Inorganic Chemicals"
                    },
                    {
                        "id": "D002254",
                        "term": "Carbonates"
                    },
                    {
                        "id": "D002255",
                        "term": "Carbonic Acid"
                    },
                    {
                        "id": "D017554",
                        "term": "Carbon Compounds, Inorganic"
                    },
                    {
                        "id": "D008903",
                        "term": "Minerals"
                    }
                ]
            }
        },
        "hasResults": true
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT01481116",
                "orgStudyIdInfo": {
                    "id": "TAK-875_304"
                },
                "secondaryIdInfos": [
                    {
                        "id": "2011-001731-24",
                        "type": "EUDRACT_NUMBER"
                    },
                    {
                        "id": "U1111-1124-2296",
                        "type": "REGISTRY",
                        "domain": "WHO"
                    },
                    {
                        "id": "TAK-875_304CTIL",
                        "type": "OTHER",
                        "domain": "Israel MOH"
                    },
                    {
                        "id": "DOH-27-0512-3913",
                        "type": "REGISTRY",
                        "domain": "SANCTR"
                    },
                    {
                        "id": "11-057",
                        "type": "REGISTRY",
                        "domain": "ROCTR"
                    },
                    {
                        "id": "NMRR-11-882-10318",
                        "type": "REGISTRY",
                        "domain": "NMRR"
                    },
                    {
                        "id": "HKCTR-1616",
                        "type": "REGISTRY",
                        "domain": "HKUCTR"
                    },
                    {
                        "id": "262",
                        "type": "REGISTRY",
                        "domain": "RoPCCT"
                    },
                    {
                        "id": "12/WA/0245",
                        "type": "REGISTRY",
                        "domain": "NRES"
                    }
                ],
                "organization": {
                    "fullName": "Takeda",
                    "class": "INDUSTRY"
                },
                "briefTitle": "Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes",
                "officialTitle": "A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination With Metformin in Subjects With Type 2 Diabetes"
            },
            "statusModule": {
                "statusVerifiedDate": "2016-04",
                "overallStatus": "TERMINATED",
                "whyStopped": "Due to potential concerns about liver safety (See Detailed Description)",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2012-01"
                },
                "primaryCompletionDateStruct": {
                    "date": "2014-03",
                    "type": "ACTUAL"
                },
                "completionDateStruct": {
                    "date": "2014-04",
                    "type": "ACTUAL"
                },
                "studyFirstSubmitDate": "2011-11-25",
                "studyFirstSubmitQcDate": "2011-11-25",
                "studyFirstPostDateStruct": {
                    "date": "2011-11-29",
                    "type": "ESTIMATED"
                },
                "resultsFirstSubmitDate": "2015-07-24",
                "resultsFirstSubmitQcDate": "2016-04-24",
                "resultsFirstPostDateStruct": {
                    "date": "2016-06-01",
                    "type": "ESTIMATED"
                },
                "lastUpdateSubmitDate": "2016-04-24",
                "lastUpdatePostDateStruct": {
                    "date": "2016-06-01",
                    "type": "ESTIMATED"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "Takeda",
                    "class": "INDUSTRY"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true
            },
            "descriptionModule": {
                "briefSummary": "The purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), plus metformin compared to glimepiride plus metformin in participants with type 2 diabetes mellitus (T2DM).\n\nThe purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), plus metformin compared to glimepiride plus metformin in participants with type 2 diabetes mellitus (T2DM).",
                "detailedDescription": "Type 2 diabetes mellitus (T2DM) has increased dramatically throughout the world over the past decades despite the availability of several different treatment options. Current pharmacologic treatments include insulin, thiazolidinediones, sulfonylureas, metformin, dipeptidyl-peptidase-4 (DPP-4) inhibitors, and glucagon-like peptide-1 (GLP-1) mimetics. A number of these treatments are associated with clinically important side effects such as low blood sugar (hypoglycemia), weight gainflud retention, exaggeration of pre-existent heart failure, and gastrointestinal side effects. These side effects and the disadvantages associated with many of the currently available antidiabetic agents can reduce compliance and limit their long-term use.\n\nInsulin is a hormone that is produced by the body to regulate blood sugar (glucose). In individuals with T2DM, the insulin produced by the body does not effectively control the amount of sugar in the bloodstream. If not properly managed, T2DM may cause elevated blood sugar levels (hyperglycemia) and ultimately result in serious health problems.\n\nIn response to this problem, Takeda is developing TAK-875 (an investigational drug) as an addition to diet and exercise to improve blood sugar control in patients with T2DM. TAK-875 may affect the production of insulin and may improve how the body uses the sugar in the blood.\n\nThe aim of this study is to find out if TAK-875, when taken for approximately 2 years in combination with current diabetes medicine (called metformin), is safe and effective at helping people with T2DM control their high blood sugar when compared to glimepiride (a type of medication called a sulfonylurea). The study is being done to find out if the combination of TAK-875 plus metformin works as well as the combination of glimepiride plus metformin.\n\nApproximately 2430 patients worldwide aged 18 or over with T2DM, will take part in this study and will be involved in the study for up to 110 or 120 weeks.\n\nTAK-875 is being developed at Takeda Global Research and Development, Inc. as an adjunct to diet and exercise to improve glycemic control in participants with T2DM.\n\nThis study will investigate TAK-875 in participants with type 2 diabetes mellitus whose blood sugar level is inadequately controlled with metformin monotherapy.\n\nDue to potential concerns about liver safety, on balance, the benefits of treating patients with fasiglifam (TAK-875) do not outweigh the potential risks.\n\nFor this reason, Takeda has decided voluntarily to terminate the development activities for fasiglifam."
            },
            "conditionsModule": {
                "conditions": [
                    "Diabetes Mellitus, Type 2"
                ],
                "keywords": [
                    "Drug Therapy"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE3"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "QUADRUPLE",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR",
                            "OUTCOMES_ASSESSOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 2454,
                    "type": "ACTUAL"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "TAK-875 25 mg QD",
                        "type": "EXPERIMENTAL",
                        "interventionNames": [
                            "Drug: TAK-875"
                        ]
                    },
                    {
                        "label": "TAK-875 50 mg QD",
                        "type": "EXPERIMENTAL",
                        "interventionNames": [
                            "Drug: TAK-875"
                        ]
                    },
                    {
                        "label": "Glimepiride 1-2 mg QD",
                        "type": "ACTIVE_COMPARATOR",
                        "interventionNames": [
                            "Drug: Glimepiride"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "TAK-875",
                        "description": "TAK-875 25 mg, tablets, orally, once daily and metformin \u22651500 mg or Maximum Tolerated Dose (MTD) for up to 104 weeks.",
                        "armGroupLabels": [
                            "TAK-875 25 mg QD"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "TAK-875",
                        "description": "TAK-875 50 mg, tablets, orally, once daily and metformin \u22651500 mg or MTD for up to 104 weeks.",
                        "armGroupLabels": [
                            "TAK-875 50 mg QD"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Glimepiride",
                        "description": "Glimepiride 1 mg, tablets, orally, once daily (up-titrated to 2 mg after 1 week of treatment. Up-titrated to a maximum of 6 mg in 2 mg increments/down titrated if recurrent (or severe) hypoglycemia occurs) and metformin \u22651500 mg or MTD for up to 104 weeks.",
                        "armGroupLabels": [
                            "Glimepiride 1-2 mg QD"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Change From Baseline in HbA1c at Weeks 78 and 104",
                        "description": "The change in the value of HbA1c (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) to be collected at Weeks 78 and 104 relative to baseline.",
                        "timeFrame": "Baseline and Weeks 78 and 104"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Percentage of Participants With Hypoglycemia",
                        "description": "Participants were provided diaries to document any hypoglycemic events that occurred between study visits. Any experience of hypoglycemic signs and symptoms (regardless of the blood glucose value by glucometer) or had a blood glucose value less than or equal to (\\<=) 70 milligram per deciliter (mg/dL) (3.9 millimole per liter (mmol/L) by glucometer (regardless of symptoms) were to be recorded.",
                        "timeFrame": "Day 1 up to Weeks 78 and 104"
                    },
                    {
                        "measure": "Change From Baseline in Body Weight at Weeks 78 and 104",
                        "description": "The change between the body weight to be collected at Weeks 78 and 104 relative to baseline.",
                        "timeFrame": "Baseline and Weeks 78 and 104"
                    },
                    {
                        "measure": "Change From Baseline in HbA1c at Weeks 26 and 52",
                        "description": "The change in the value of HbA1c collected at Weeks 26 and 52 relative to baseline.",
                        "timeFrame": "Baseline and Weeks 26 and 52"
                    },
                    {
                        "measure": "Percentage of Participants With HbA1c <7%",
                        "timeFrame": "Weeks 26, 52, 78 and 104"
                    },
                    {
                        "measure": "Percentage of Participants With HbA1c <7% for Participants Who Did Not Report Hypoglycemia",
                        "timeFrame": "Weeks 26, 52, 78 and 104"
                    },
                    {
                        "measure": "Change From Baseline in Fasting Plasma Glucose at Weeks 26, 52, 78 and 104",
                        "description": "The change between the fasting plasma glucose value to be collected at Weeks 26, 52, 78 and 104 relative to baseline.",
                        "timeFrame": "Baseline and Weeks 26, 52, 78 and 104"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion Criteria:\n\n1. In the opinion of the investigator, the participant is capable of understanding and complying with protocol requirements.\n2. The participant or, when applicable, the participant's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.\n3. The participant is male or female and 18 years of age or older with a historical diagnosis of T2DM.\n4. The participant meets one of the following criteria:\n\n   1. The participant has an HbA1c level \u22657.0 and \\<10.0%, and has been on a stable daily dose of \u22651500 mg (or documented MTD) of metformin for at least 2 months prior to Screening. This participant will immediately enter the Placebo Run-in Period, or;\n   2. The participant has an HbA1c level \u2265 7.5 and \\<10.5%, and has been on a stable daily dose of \\<1500 mg of metformin without documented MTD for at least 2 months prior to Screening. After completing the Screening Visit, this participant will have their metformin dose immediately increased to \u22651500 mg (or MTD) for an 8-week Titration Period. Following this 8-week period, the participant must qualify for entry into the Placebo Run-in Period by completing the Week -3 procedures and having an HbA1c concentration \u22657.0 and \\<10.0%.\n5. The participant has had no treatment with antidiabetic agents other than metformin within 2 months prior to Screening (Exception: if a participant has received other antidiabetic therapy for \u22647 days within the 2 months prior to Screening).\n6. The participant has a body mass index (BMI) of \u226445 kg/m2 at Screening.\n7. Participants regularly using other, non-excluded medications, must be on a stable dose for at least 4 weeks prior to Screening. However, PRN (as needed) use of prescription or over-the-counter medications is allowed at the discretion of the investigator.\n8. The participant is able and willing to monitor glucose with a home glucose monitor and consistently record his or her own blood glucose concentrations and complete participant diaries.\n\nAdditional Inclusion Criteria Prior to Randomization\n\n1. The participant has an HbA1c concentration \u22657.0% and \\<10.0%, and a FPG \u2264270 mg/dL (15.0 mmol/L) at the Week -1 Visit. (If the subject does not qualify for randomization based on these criteria, the assessment may be repeated weekly, for a maximum of 2 additional weeks).\n2. The participant's compliance with the single-blind study medication during the Placebo Run-in Period is at least 75% and does not exceed 125% based on tablet/capsule counts performed by the study staff.\n3. A female participant of childbearing potential must have a negative urine hCG pregnancy test at Baseline (Day 1) prior to Randomization and prior to administration of the first dose of double-blind study medication.\n\nExclusion Criteria:\n\n1. The participant has received any investigational compound within 30 days prior to Screening or has received an investigational antidiabetic drug within the 3 months prior to Screening.\n2. The participant has been randomized into a previous TAK-875 study\n3. The participant is an immediate family member, study site employee, or is in a dependant relationship with a study site employee who is involved in conduct of this study (e.g., spouse, parent, child, sibling) or may consent under duress.\n4. The participant donated or received any blood products within 12 weeks prior to Screening or is planning to donate blood during the study.\n5. The participant has a hemoglobin \u226412 g/dL (\u2264120 gm/L) for males and \u226410 g/dL (\u2264100 gm/L) for females at Screening.\n6. The participant has a systolic blood pressure \u2265160 mm Hg or diastolic pressure \u226595 mm Hg at Screening (If the participant meets this exclusion criterion, the assessment may be repeated once at least 30 minutes after the initial measurement).\n7. The participant has history of cancer that has been in remission for \\<5 years prior to Screening. A history of basal cell carcinoma or stage 1 squamous cell carcinoma of the skin is allowed.\n8. The participant has alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels \\>2.0x upper limit of normal (ULN) at Screening.\n9. The participant has a total bilirubin level greater than the ULN at Screening. Exception: if a participant has documented Gilbert's Syndrome the participant will be allowed with an elevated bilirubin level per the investigator's discretion.\n10. The participant has a serum creatinine \u22651.5 mg/dL(males) and \u22651.4 mg/dL(females) and/or estimated glomerular filtration rate (GFR) \\<60 mL/min/1.73m2 at Screening.\n11. The participant has uncontrolled thyroid disease.\n12. The participant has a history of laser treatment for proliferative diabetic retinopathy within 6 months prior to Screening.\n13. The participant has had gastric banding, or gastric bypass surgery within one year prior to Screening.\n14. The participant has a known history of infection with human immunodeficiency virus (HIV), Hepatitis B virus (HBV), or Hepatitis C virus (HCV).\n15. The participant had coronary angioplasty, coronary stent placement, coronary bypass surgery, myocardial infarction, unstable angina pectoris, clinically significant abnormal electrocardiogram (ECG), cerebrovascular accident or transient ischemic attack within 3 months prior to or at Screening.\n16. The participant has a history of hypersensitivity, allergies, or has had an anaphylactic reaction(s) to any component of TAK-875, metformin, or glimepiride.\n17. The participant has a history of drug abuse (defined as illicit drug use) or a history of alcohol abuse within 2 years prior to Screening.\n18. The participant received excluded medications prior to Screening or is expected to receive excluded medication.\n19. If female, the participant is pregnant (confirmed by laboratory testing, i.e., serum/urine human chorionic gonadotropin (hCG), in females of childbearing potential) or lactating or intending to become pregnant before, during, or within 1 month after participating in this study; or intending to donate ova during such time period.\n20. The participant is unable to understand verbal or written English or any other language for which a certified translation of the approved informed consent is available.\n21. The participant has any other physical or psychiatric disease or condition that in the judgment of the investigator may affect life expectancy or may make it difficult to successfully manage and follow the participant according to the protocol.\n\nAdditional Exclusion Criteria Prior to Randomization\n\n1. The participant has received excluded medications listed in the protocol during the Placebo Run-in Period (topical and inhaled corticosteroids are allowed).\n2. The participant has a systolic blood pressure \u2265160 mm Hg or diastolic blood pressure \u226595 mm Hg at Baseline (Day 1) (If the subject meets this exclusion criterion, the assessment may be repeated once at least 30 minutes after the initial measurement and decision will be made based on the second measurement).\n3. The participant has a serum creatinine \u22651.5 mg/dL(\u2265133\u00b5mol/L) \\[males\\] and \u22651.4 mg/dL (\u2265124 \u00b5mol/L) \\[females\\] and/or estimated glomerular filtration rate (GFR) \\<60 mL/min/1.73m2 at Visit 3 (Schedule B subjects only).",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "18 Years",
                "stdAges": [
                    "ADULT",
                    "OLDER_ADULT"
                ]
            },
            "contactsLocationsModule": {
                "overallOfficials": [
                    {
                        "name": "Senior Medical Director",
                        "affiliation": "Takeda",
                        "role": "STUDY_DIRECTOR"
                    }
                ],
                "locations": [
                    {
                        "city": "Dothan",
                        "state": "Alabama",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 31.22323,
                            "lon": -85.39049
                        }
                    },
                    {
                        "city": "Muscle Shoals",
                        "state": "Alabama",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.74481,
                            "lon": -87.66753
                        }
                    },
                    {
                        "city": "Goodyear",
                        "state": "Arizona",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.43532,
                            "lon": -112.35821
                        }
                    },
                    {
                        "city": "Phoenix",
                        "state": "Arizona",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.44838,
                            "lon": -112.07404
                        }
                    },
                    {
                        "city": "Tempe",
                        "state": "Arizona",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.41477,
                            "lon": -111.90931
                        }
                    },
                    {
                        "city": "Long Beach",
                        "state": "California",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.76696,
                            "lon": -118.18923
                        }
                    },
                    {
                        "city": "Mission Hills",
                        "state": "California",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.68609,
                            "lon": -120.43683
                        }
                    },
                    {
                        "city": "North Hollywood",
                        "state": "California",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.17223,
                            "lon": -118.37897
                        }
                    },
                    {
                        "city": "Norwalk",
                        "state": "California",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.90224,
                            "lon": -118.08173
                        }
                    },
                    {
                        "city": "Pismo Beach",
                        "state": "California",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.14275,
                            "lon": -120.64128
                        }
                    },
                    {
                        "city": "Bradenton",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 27.49893,
                            "lon": -82.57482
                        }
                    },
                    {
                        "city": "Clearwater",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 27.96585,
                            "lon": -82.8001
                        }
                    },
                    {
                        "city": "Coral Gables",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 25.72149,
                            "lon": -80.26838
                        }
                    },
                    {
                        "city": "Hialeah",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 25.8576,
                            "lon": -80.27811
                        }
                    },
                    {
                        "city": "Orlando",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 28.53834,
                            "lon": -81.37924
                        }
                    },
                    {
                        "city": "Pembroke Pines",
                        "state": "Florida",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 26.00315,
                            "lon": -80.22394
                        }
                    },
                    {
                        "city": "Decatur",
                        "state": "Georgia",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.77483,
                            "lon": -84.29631
                        }
                    },
                    {
                        "city": "Avon",
                        "state": "Indiana",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.76282,
                            "lon": -86.39972
                        }
                    },
                    {
                        "city": "Topeka",
                        "state": "Kansas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.04833,
                            "lon": -95.67804
                        }
                    },
                    {
                        "city": "Oxon Hill",
                        "state": "Maryland",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.80345,
                            "lon": -76.9897
                        }
                    },
                    {
                        "city": "Flint",
                        "state": "Michigan",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 43.01253,
                            "lon": -83.68746
                        }
                    },
                    {
                        "city": "Jackson",
                        "state": "Mississippi",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 32.29876,
                            "lon": -90.18481
                        }
                    },
                    {
                        "city": "Omaha",
                        "state": "Nebraska",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.25626,
                            "lon": -95.94043
                        }
                    },
                    {
                        "city": "Elizabeth",
                        "state": "New Jersey",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 40.66399,
                            "lon": -74.2107
                        }
                    },
                    {
                        "city": "Calabash",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.89073,
                            "lon": -78.56834
                        }
                    },
                    {
                        "city": "Charlotte",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.22709,
                            "lon": -80.84313
                        }
                    },
                    {
                        "city": "Greensboro",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 36.07264,
                            "lon": -79.79198
                        }
                    },
                    {
                        "city": "Mooresville",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.58486,
                            "lon": -80.81007
                        }
                    },
                    {
                        "city": "Morganton",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.74541,
                            "lon": -81.68482
                        }
                    },
                    {
                        "city": "Raleigh",
                        "state": "North Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.7721,
                            "lon": -78.63861
                        }
                    },
                    {
                        "city": "Maumee",
                        "state": "Ohio",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.56283,
                            "lon": -83.65382
                        }
                    },
                    {
                        "city": "Oklahoma City",
                        "state": "Oklahoma",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.46756,
                            "lon": -97.51643
                        }
                    },
                    {
                        "city": "Greer",
                        "state": "South Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.93873,
                            "lon": -82.22706
                        }
                    },
                    {
                        "city": "Spartanburg",
                        "state": "South Carolina",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 34.94957,
                            "lon": -81.93205
                        }
                    },
                    {
                        "city": "Dallas",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 32.78306,
                            "lon": -96.80667
                        }
                    },
                    {
                        "city": "El Paso",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 31.75872,
                            "lon": -106.48693
                        }
                    },
                    {
                        "city": "Fort Worth",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 32.72541,
                            "lon": -97.32085
                        }
                    },
                    {
                        "city": "Houston",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 29.76328,
                            "lon": -95.36327
                        }
                    },
                    {
                        "city": "New Braunfels",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 29.703,
                            "lon": -98.12445
                        }
                    },
                    {
                        "city": "San Antonio",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 29.42412,
                            "lon": -98.49363
                        }
                    },
                    {
                        "city": "Spring",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 30.07994,
                            "lon": -95.41716
                        }
                    },
                    {
                        "city": "Tomball",
                        "state": "Texas",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 30.09716,
                            "lon": -95.61605
                        }
                    },
                    {
                        "city": "Salt Lake City",
                        "state": "Utah",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 40.76078,
                            "lon": -111.89105
                        }
                    },
                    {
                        "city": "Burke",
                        "state": "Virginia",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.79345,
                            "lon": -77.27165
                        }
                    },
                    {
                        "city": "Hampton",
                        "state": "Virginia",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 37.02987,
                            "lon": -76.34522
                        }
                    },
                    {
                        "city": "Manassas",
                        "state": "Virginia",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.75095,
                            "lon": -77.47527
                        }
                    },
                    {
                        "city": "Buenos Aires",
                        "state": "Ciudad Autonoma Buenos Aires",
                        "country": "Argentina",
                        "geoPoint": {
                            "lat": -34.61315,
                            "lon": -58.37723
                        }
                    },
                    {
                        "city": "Ciudad Autonoma Buenos Aires",
                        "state": "Ciudad Autonoma Buenos Aires",
                        "country": "Argentina"
                    },
                    {
                        "city": "Corrientes",
                        "state": "Corrientes Province",
                        "country": "Argentina",
                        "geoPoint": {
                            "lat": -27.46784,
                            "lon": -58.8344
                        }
                    },
                    {
                        "city": "C\u00f3rdoba",
                        "state": "C\u00f3rdoba Province",
                        "country": "Argentina",
                        "geoPoint": {
                            "lat": -31.40648,
                            "lon": -64.18853
                        }
                    },
                    {
                        "city": "Rosario",
                        "state": "Santa Fe Province",
                        "country": "Argentina",
                        "geoPoint": {
                            "lat": -32.94682,
                            "lon": -60.63932
                        }
                    },
                    {
                        "city": "C\u00f3rdoba",
                        "country": "Argentina",
                        "geoPoint": {
                            "lat": -31.40648,
                            "lon": -64.18853
                        }
                    },
                    {
                        "city": "Canberra",
                        "state": "Australian Capital Territory",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -35.28346,
                            "lon": 149.12807
                        }
                    },
                    {
                        "city": "Brookvale",
                        "state": "New South Wales",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.76108,
                            "lon": 151.27446
                        }
                    },
                    {
                        "city": "Mosman",
                        "state": "New South Wales",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.83902,
                            "lon": 151.23956
                        }
                    },
                    {
                        "city": "Woy Woy",
                        "state": "New South Wales",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.48433,
                            "lon": 151.32471
                        }
                    },
                    {
                        "city": "Canberra",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -35.28346,
                            "lon": 149.12807
                        }
                    },
                    {
                        "city": "Blagoevgrad",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.01457,
                            "lon": 23.09804
                        }
                    },
                    {
                        "city": "Gabrovo",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.87419,
                            "lon": 25.31823
                        }
                    },
                    {
                        "city": "Pleven",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 43.41791,
                            "lon": 24.61666
                        }
                    },
                    {
                        "city": "Plovdiv",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.15387,
                            "lon": 24.75001
                        }
                    },
                    {
                        "city": "Sevlievo",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 43.02295,
                            "lon": 25.10364
                        }
                    },
                    {
                        "city": "Sofia",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.69751,
                            "lon": 23.32415
                        }
                    },
                    {
                        "city": "Stara Zagora",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.43205,
                            "lon": 25.64262
                        }
                    },
                    {
                        "city": "Varna",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 43.21912,
                            "lon": 27.91024
                        }
                    },
                    {
                        "city": "Victoria",
                        "state": "British Columbia",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 48.4359,
                            "lon": -123.35155
                        }
                    },
                    {
                        "city": "Oakville",
                        "state": "Ontario",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 43.45011,
                            "lon": -79.68292
                        }
                    },
                    {
                        "city": "Ottawa",
                        "state": "Ontario",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.41117,
                            "lon": -75.69812
                        }
                    },
                    {
                        "city": "Thornhill",
                        "state": "Ontario",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 43.80011,
                            "lon": -79.4163
                        }
                    },
                    {
                        "city": "Toronto",
                        "state": "Ontario",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 43.70643,
                            "lon": -79.39864
                        }
                    },
                    {
                        "city": "Laval",
                        "state": "Quebec",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.56995,
                            "lon": -73.692
                        }
                    },
                    {
                        "city": "Longueuil",
                        "state": "Quebec",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.5152,
                            "lon": -73.46818
                        }
                    },
                    {
                        "city": "Mirabel",
                        "state": "Quebec",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.65008,
                            "lon": -74.08251
                        }
                    },
                    {
                        "city": "Pointe-Claire",
                        "state": "Quebec",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.44868,
                            "lon": -73.81669
                        }
                    },
                    {
                        "city": "Saint-Laurent",
                        "state": "Quebec",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.50008,
                            "lon": -73.66585
                        }
                    },
                    {
                        "city": "Bogot\u00e1",
                        "country": "Colombia",
                        "geoPoint": {
                            "lat": 4.60971,
                            "lon": -74.08175
                        }
                    },
                    {
                        "city": "Medell\u00edn",
                        "country": "Colombia",
                        "geoPoint": {
                            "lat": 6.245,
                            "lon": -75.57151
                        }
                    },
                    {
                        "city": "Ben\u00e1tky nad Jizerou",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 50.29085,
                            "lon": 14.82343
                        }
                    },
                    {
                        "city": "Brno",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 49.19522,
                            "lon": 16.60796
                        }
                    },
                    {
                        "city": "Choce\u0148",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 50.00161,
                            "lon": 16.22303
                        }
                    },
                    {
                        "city": "\u010cesk\u00e9 Bud\u011bjovice",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 48.97447,
                            "lon": 14.47434
                        }
                    },
                    {
                        "city": "Jind\u0159ich\u016fv Hradec",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 49.14404,
                            "lon": 15.00301
                        }
                    },
                    {
                        "city": "Mari\u00e1nsk\u00e9 L\u00e1zn\u011b",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 49.96459,
                            "lon": 12.70118
                        }
                    },
                    {
                        "city": "Olomouc",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 49.59552,
                            "lon": 17.25175
                        }
                    },
                    {
                        "city": "Ostrava",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 49.83465,
                            "lon": 18.28204
                        }
                    },
                    {
                        "city": "Ostrava - Moravska Ostrava",
                        "country": "Czechia"
                    },
                    {
                        "city": "Ostrava - Vitkovice",
                        "country": "Czechia"
                    },
                    {
                        "city": "Prague",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 50.08804,
                            "lon": 14.42076
                        }
                    },
                    {
                        "city": "Praha 4 - Krc",
                        "country": "Czechia"
                    },
                    {
                        "city": "Znojmo",
                        "country": "Czechia",
                        "geoPoint": {
                            "lat": 48.8555,
                            "lon": 16.0488
                        }
                    },
                    {
                        "city": "Paide",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 58.88768,
                            "lon": 25.54042
                        }
                    },
                    {
                        "city": "Rakvere",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 59.34808,
                            "lon": 26.35784
                        }
                    },
                    {
                        "city": "Saku",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 59.30354,
                            "lon": 24.66382
                        }
                    },
                    {
                        "city": "Tallinn",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 59.43696,
                            "lon": 24.75353
                        }
                    },
                    {
                        "city": "Tartu",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 58.38062,
                            "lon": 26.72509
                        }
                    },
                    {
                        "city": "V\u00f5ru",
                        "country": "Estonia",
                        "geoPoint": {
                            "lat": 57.83389,
                            "lon": 27.01944
                        }
                    },
                    {
                        "city": "Hong Kong",
                        "country": "Hong Kong",
                        "geoPoint": {
                            "lat": 22.27832,
                            "lon": 114.17469
                        }
                    },
                    {
                        "city": "New Territories",
                        "country": "Hong Kong",
                        "geoPoint": {
                            "lat": 22.42441,
                            "lon": 114.11095
                        }
                    },
                    {
                        "city": "Ashkelon",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 31.66926,
                            "lon": 34.57149
                        }
                    },
                    {
                        "city": "Beer Yaakov",
                        "country": "Israel"
                    },
                    {
                        "city": "Beersheba",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 31.25181,
                            "lon": 34.7913
                        }
                    },
                    {
                        "city": "Giv\u2018atayim",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.07225,
                            "lon": 34.81253
                        }
                    },
                    {
                        "city": "Hadera",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.44192,
                            "lon": 34.9039
                        }
                    },
                    {
                        "city": "Haifa",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.81303,
                            "lon": 34.99928
                        }
                    },
                    {
                        "city": "Holon",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.01034,
                            "lon": 34.77918
                        }
                    },
                    {
                        "city": "Jerusalem",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 31.76904,
                            "lon": 35.21633
                        }
                    },
                    {
                        "city": "Kfar Saba",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.175,
                            "lon": 34.90694
                        }
                    },
                    {
                        "city": "Nahariya",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 33.00892,
                            "lon": 35.09814
                        }
                    },
                    {
                        "city": "Petah Tikva",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.08707,
                            "lon": 34.88747
                        }
                    },
                    {
                        "city": "Raanana",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.1836,
                            "lon": 34.87386
                        }
                    },
                    {
                        "city": "Ramat Gan",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.08227,
                            "lon": 34.81065
                        }
                    },
                    {
                        "city": "Rehovot",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 31.89421,
                            "lon": 34.81199
                        }
                    },
                    {
                        "city": "Rishon LeZiyyon",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 31.97102,
                            "lon": 34.78939
                        }
                    },
                    {
                        "city": "Safed",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.96465,
                            "lon": 35.496
                        }
                    },
                    {
                        "city": "Tel Aviv",
                        "country": "Israel",
                        "geoPoint": {
                            "lat": 32.08088,
                            "lon": 34.78057
                        }
                    },
                    {
                        "city": "Jelgava",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 56.65,
                            "lon": 23.71278
                        }
                    },
                    {
                        "city": "Limba\u017ei",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 57.51287,
                            "lon": 24.71941
                        }
                    },
                    {
                        "city": "Ogre",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 56.8162,
                            "lon": 24.61401
                        }
                    },
                    {
                        "city": "Riga",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 56.946,
                            "lon": 24.10589
                        }
                    },
                    {
                        "city": "Talsi",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 57.24562,
                            "lon": 22.58137
                        }
                    },
                    {
                        "city": "Valmiera",
                        "country": "Latvia",
                        "geoPoint": {
                            "lat": 57.54108,
                            "lon": 25.42751
                        }
                    },
                    {
                        "city": "Alytus",
                        "country": "Lithuania",
                        "geoPoint": {
                            "lat": 54.39574,
                            "lon": 24.03885
                        }
                    },
                    {
                        "city": "Kaunas",
                        "country": "Lithuania",
                        "geoPoint": {
                            "lat": 54.90156,
                            "lon": 23.90909
                        }
                    },
                    {
                        "city": "Klaip\u0117da",
                        "country": "Lithuania",
                        "geoPoint": {
                            "lat": 55.7068,
                            "lon": 21.13912
                        }
                    },
                    {
                        "city": "Vilnius",
                        "country": "Lithuania",
                        "geoPoint": {
                            "lat": 54.68916,
                            "lon": 25.2798
                        }
                    },
                    {
                        "city": "Kuala Lumpur",
                        "state": "Kuala Lumpur",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 3.1412,
                            "lon": 101.68653
                        }
                    },
                    {
                        "city": "Malacca",
                        "state": "Melaka",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 2.196,
                            "lon": 102.2405
                        }
                    },
                    {
                        "city": "Ipoh",
                        "state": "Perak",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 4.5841,
                            "lon": 101.0829
                        }
                    },
                    {
                        "city": "Taiping",
                        "state": "Perak",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 4.85,
                            "lon": 100.73333
                        }
                    },
                    {
                        "city": "Taiping, Perak",
                        "state": "Perak",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 4.85,
                            "lon": 100.73333
                        }
                    },
                    {
                        "city": "Putrajaya",
                        "state": "Putrajaya",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 2.93527,
                            "lon": 101.69112
                        }
                    },
                    {
                        "city": "Petaling Jaya",
                        "state": "Selangor",
                        "country": "Malaysia",
                        "geoPoint": {
                            "lat": 3.10726,
                            "lon": 101.60671
                        }
                    },
                    {
                        "city": "Terengganu",
                        "state": "Terengganu",
                        "country": "Malaysia"
                    },
                    {
                        "city": "Terengganu",
                        "country": "Malaysia"
                    },
                    {
                        "city": "Mexico City",
                        "state": "Mexico City",
                        "country": "Mexico",
                        "geoPoint": {
                            "lat": 19.42847,
                            "lon": -99.12766
                        }
                    },
                    {
                        "city": "Cuernavaca",
                        "state": "Morelos",
                        "country": "Mexico",
                        "geoPoint": {
                            "lat": 18.9261,
                            "lon": -99.23075
                        }
                    },
                    {
                        "city": "Auckland",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -36.84853,
                            "lon": 174.76349
                        }
                    },
                    {
                        "city": "Christchurch",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -43.53333,
                            "lon": 172.63333
                        }
                    },
                    {
                        "city": "Hamilton",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -37.78333,
                            "lon": 175.28333
                        }
                    },
                    {
                        "city": "Palmerston North",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -40.35636,
                            "lon": 175.61113
                        }
                    },
                    {
                        "city": "Rotorua",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -38.13874,
                            "lon": 176.24516
                        }
                    },
                    {
                        "city": "Tauranga",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -37.68611,
                            "lon": 176.16667
                        }
                    },
                    {
                        "city": "Wellington",
                        "country": "New Zealand",
                        "geoPoint": {
                            "lat": -41.28664,
                            "lon": 174.77557
                        }
                    },
                    {
                        "city": "Cebu City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 10.31672,
                            "lon": 123.89071
                        }
                    },
                    {
                        "city": "Davao City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 7.07306,
                            "lon": 125.61278
                        }
                    },
                    {
                        "city": "Iloilo City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 10.69694,
                            "lon": 122.56444
                        }
                    },
                    {
                        "city": "Lipa City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 13.9411,
                            "lon": 121.1631
                        }
                    },
                    {
                        "city": "Quezon City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 14.6488,
                            "lon": 121.0509
                        }
                    },
                    {
                        "city": "Tarlac City",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 15.48017,
                            "lon": 120.59794
                        }
                    },
                    {
                        "city": "Taytay",
                        "country": "Philippines",
                        "geoPoint": {
                            "lat": 14.55883,
                            "lon": 121.13285
                        }
                    },
                    {
                        "city": "Bialystok",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 53.13333,
                            "lon": 23.16433
                        }
                    },
                    {
                        "city": "Bydgoszcz",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 53.1235,
                            "lon": 18.00762
                        }
                    },
                    {
                        "city": "Gdansk",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 54.35227,
                            "lon": 18.64912
                        }
                    },
                    {
                        "city": "Grodzisk Mazowiecki",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 52.10387,
                            "lon": 20.6337
                        }
                    },
                    {
                        "city": "Kamieniec Z\u0105bkowicki",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.52541,
                            "lon": 16.87921
                        }
                    },
                    {
                        "city": "Katowice",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.2597,
                            "lon": 19.02173
                        }
                    },
                    {
                        "city": "Lodz",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.77058,
                            "lon": 19.47395
                        }
                    },
                    {
                        "city": "Lublin",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.25058,
                            "lon": 22.57009
                        }
                    },
                    {
                        "city": "O\u015bwi\u0119cim",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.03437,
                            "lon": 19.21037
                        }
                    },
                    {
                        "city": "Parczew",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.64021,
                            "lon": 22.90057
                        }
                    },
                    {
                        "city": "Poznan",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 52.40692,
                            "lon": 16.92993
                        }
                    },
                    {
                        "city": "Pu\u0142awy",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.41655,
                            "lon": 21.96939
                        }
                    },
                    {
                        "city": "P\u0142ock",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 52.54682,
                            "lon": 19.70638
                        }
                    },
                    {
                        "city": "Ruda \u015al\u0105ska",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.2584,
                            "lon": 18.85632
                        }
                    },
                    {
                        "city": "Rzesz\u00f3w",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.04132,
                            "lon": 21.99901
                        }
                    },
                    {
                        "city": "Sopot",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 54.4418,
                            "lon": 18.56003
                        }
                    },
                    {
                        "city": "Torun",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 53.01375,
                            "lon": 18.59814
                        }
                    },
                    {
                        "city": "Wroclaw",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.10286,
                            "lon": 17.03006
                        }
                    },
                    {
                        "city": "Zgierz",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 51.85561,
                            "lon": 19.40623
                        }
                    },
                    {
                        "city": "\u0141\u0119czyca",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 52.05959,
                            "lon": 19.19972
                        }
                    },
                    {
                        "city": "Bacau",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 46.56718,
                            "lon": 26.91384
                        }
                    },
                    {
                        "city": "Baia Mare",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 47.65729,
                            "lon": 23.56808
                        }
                    },
                    {
                        "city": "Bucharest",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 44.43225,
                            "lon": 26.10626
                        }
                    },
                    {
                        "city": "Constan\u021ba",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 44.18073,
                            "lon": 28.63432
                        }
                    },
                    {
                        "city": "Ia\u0219i",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 47.16667,
                            "lon": 27.6
                        }
                    },
                    {
                        "city": "Oradea",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 47.0458,
                            "lon": 21.91833
                        }
                    },
                    {
                        "city": "Ploie\u015fti",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 44.95,
                            "lon": 26.01667
                        }
                    },
                    {
                        "city": "T\u00e2rgu Mure\u015f",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 46.54245,
                            "lon": 24.55747
                        }
                    },
                    {
                        "city": "Timi\u0219oara",
                        "country": "Romania",
                        "geoPoint": {
                            "lat": 45.75372,
                            "lon": 21.22571
                        }
                    },
                    {
                        "city": "Kazan'",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 55.78874,
                            "lon": 49.12214
                        }
                    },
                    {
                        "city": "Kemerovo",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 55.35417,
                            "lon": 86.10435
                        }
                    },
                    {
                        "city": "Krasnoyarsk",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 56.03742,
                            "lon": 92.93136
                        }
                    },
                    {
                        "city": "Moscow",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 55.75204,
                            "lon": 37.61781
                        }
                    },
                    {
                        "city": "Novosibirsk",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 55.02259,
                            "lon": 82.93175
                        }
                    },
                    {
                        "city": "Saint Petersburg",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 59.93863,
                            "lon": 30.31413
                        }
                    },
                    {
                        "city": "Yaroslavl",
                        "country": "Russia",
                        "geoPoint": {
                            "lat": 57.62987,
                            "lon": 39.87368
                        }
                    },
                    {
                        "city": "Port Elizabeth",
                        "state": "Eastern Cape",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.96109,
                            "lon": 25.61494
                        }
                    },
                    {
                        "city": "Bloemfontein",
                        "state": "Free State",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -29.12107,
                            "lon": 26.214
                        }
                    },
                    {
                        "city": "Johannesburg",
                        "state": "Gauteng",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -26.20227,
                            "lon": 28.04363
                        }
                    },
                    {
                        "city": "Kempton Park",
                        "state": "Gauteng",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -26.10859,
                            "lon": 28.2377
                        }
                    },
                    {
                        "city": "Krugersdorp",
                        "state": "Gauteng",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -26.08577,
                            "lon": 27.77515
                        }
                    },
                    {
                        "city": "Pretoria",
                        "state": "Gauteng",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -25.74486,
                            "lon": 28.18783
                        }
                    },
                    {
                        "city": "Durban",
                        "state": "KwaZulu-Natal",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -29.8579,
                            "lon": 31.0292
                        }
                    },
                    {
                        "city": "Middelburg",
                        "state": "Mpumalanga",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -25.77507,
                            "lon": 29.46482
                        }
                    },
                    {
                        "city": "Cape Town",
                        "state": "Western Cape",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.92584,
                            "lon": 18.42322
                        }
                    },
                    {
                        "city": "Somerset West",
                        "state": "Western Cape",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -34.08401,
                            "lon": 18.82113
                        }
                    },
                    {
                        "city": "Stellenbosch",
                        "state": "Western Cape",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.93462,
                            "lon": 18.86676
                        }
                    },
                    {
                        "city": "Worcester",
                        "state": "Western Cape",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.64651,
                            "lon": 19.44852
                        }
                    },
                    {
                        "city": "Chia-Yi City",
                        "country": "Taiwan"
                    },
                    {
                        "city": "New Taipei City",
                        "country": "Taiwan",
                        "geoPoint": {
                            "lat": 25.06199,
                            "lon": 121.45703
                        }
                    },
                    {
                        "city": "Taichung",
                        "country": "Taiwan",
                        "geoPoint": {
                            "lat": 24.1469,
                            "lon": 120.6839
                        }
                    },
                    {
                        "city": "Tainan City",
                        "country": "Taiwan",
                        "geoPoint": {
                            "lat": 22.99083,
                            "lon": 120.21333
                        }
                    },
                    {
                        "city": "Taipei",
                        "country": "Taiwan",
                        "geoPoint": {
                            "lat": 25.05306,
                            "lon": 121.52639
                        }
                    },
                    {
                        "city": "Dnipropetrovsk",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 48.46664,
                            "lon": 35.04066
                        }
                    },
                    {
                        "city": "Ivano-Frankivsk",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 48.92312,
                            "lon": 24.71248
                        }
                    },
                    {
                        "city": "Kharkiv",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 49.98177,
                            "lon": 36.25475
                        }
                    },
                    {
                        "city": "Kiev",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 50.45466,
                            "lon": 30.5238
                        }
                    },
                    {
                        "city": "Kyiv",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 50.45466,
                            "lon": 30.5238
                        }
                    },
                    {
                        "city": "Luhansk",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 48.56814,
                            "lon": 39.30553
                        }
                    },
                    {
                        "city": "Lviv",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 49.83826,
                            "lon": 24.02324
                        }
                    },
                    {
                        "city": "Mykolayiv",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 46.97625,
                            "lon": 31.99296
                        }
                    },
                    {
                        "city": "Poltava",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 49.58925,
                            "lon": 34.55367
                        }
                    },
                    {
                        "city": "Ternopil",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 49.55404,
                            "lon": 25.59067
                        }
                    },
                    {
                        "city": "Vinnytsia",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 49.2322,
                            "lon": 28.46871
                        }
                    },
                    {
                        "city": "Zaporizhzhia",
                        "country": "Ukraine",
                        "geoPoint": {
                            "lat": 48.03327,
                            "lon": 36.76605
                        }
                    },
                    {
                        "city": "Cardiff",
                        "state": "Cardiff",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.48,
                            "lon": -3.18
                        }
                    },
                    {
                        "city": "Cheadle",
                        "state": "Cheshire",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 52.98333,
                            "lon": -1.98333
                        }
                    },
                    {
                        "city": "Plymouth",
                        "state": "Devon",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 50.37153,
                            "lon": -4.14305
                        }
                    },
                    {
                        "city": "Hull",
                        "state": "East Riding of Yorkshire",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 53.7446,
                            "lon": -0.33525
                        }
                    },
                    {
                        "city": "Bexhill-on-Sea",
                        "state": "East Sussex",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 50.85023,
                            "lon": 0.47095
                        }
                    },
                    {
                        "city": "Watford",
                        "state": "Hertfordshire",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.65531,
                            "lon": -0.39602
                        }
                    },
                    {
                        "city": "Thornton-Cleveleys",
                        "state": "Lancashire",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 53.87389,
                            "lon": -3.02244
                        }
                    },
                    {
                        "city": "Liverpool",
                        "state": "Merseyside",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 53.41058,
                            "lon": -2.97794
                        }
                    },
                    {
                        "city": "Northwood",
                        "state": "Middlesex",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.61162,
                            "lon": -0.42454
                        }
                    },
                    {
                        "city": "Bath",
                        "state": "Somerset",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.3751,
                            "lon": -2.36172
                        }
                    },
                    {
                        "city": "Swansea",
                        "state": "South Glamorgan",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.62079,
                            "lon": -3.94323
                        }
                    }
                ]
            },
            "referencesModule": {
                "references": [
                    {
                        "pmid": "30880443",
                        "type": "DERIVED",
                        "citation": "Shavadia JS, Sharma A, Gu X, Neaton J, DeLeve L, Holmes D, Home P, Eckel RH, Watkins PB, Granger CB. Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program. Clin Trials. 2019 Jun;16(3):253-262. doi: 10.1177/1740774519836766. Epub 2019 Mar 18."
                    }
                ]
            }
        },
        "resultsSection": {
            "participantFlowModule": {
                "preAssignmentDetails": "Participants with a historical diagnosis of type 2 diabetes mellitus who were inadequately controlled while receiving metformin alone were enrolled in 1 of 3 treatment groups as follows: glimepiride; TAK-875 25 milligram (mg); TAK-875 50 mg.",
                "recruitmentDetails": "Participants took part at 291 sites in Argentina, Australia, Bulgaria, Canada, Colombia, Czech Republic, Estonia, Hong Kong, Israel, Latvia, Lithuania, Malaysia, Mexico, New Zealand, Philippines, Poland, Romania, the Russian Federation, South Africa, Taiwan, Ukraine, the United Kingdom and the United States from 06 November 2011 to 24 April 2014.",
                "groups": [
                    {
                        "id": "FG000",
                        "title": "Glimepiride",
                        "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                    },
                    {
                        "id": "FG001",
                        "title": "TAK-875 25 mg",
                        "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                    },
                    {
                        "id": "FG002",
                        "title": "TAK-875 50 mg",
                        "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                    }
                ],
                "periods": [
                    {
                        "title": "Overall Study",
                        "milestones": [
                            {
                                "type": "STARTED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "824"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "817"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "813"
                                    }
                                ]
                            },
                            {
                                "type": "Treated",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "822"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "816"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "813"
                                    }
                                ]
                            },
                            {
                                "type": "COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "NOT COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "824"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "817"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "813"
                                    }
                                ]
                            }
                        ],
                        "dropWithdraws": [
                            {
                                "type": "Adverse Event",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "26"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "26"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "42"
                                    }
                                ]
                            },
                            {
                                "type": "Major Protocol Deviation",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "3"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "7"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Lost to Follow-up",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "8"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "12"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "11"
                                    }
                                ]
                            },
                            {
                                "type": "Withdrawal by Subject",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "37"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "33"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "37"
                                    }
                                ]
                            },
                            {
                                "type": "Study Termination",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "730"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "729"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "713"
                                    }
                                ]
                            },
                            {
                                "type": "Pregnancy",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Lack of Efficacy",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "3"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "3"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Contraindications",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Other",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Participant Started Taking Glipizide",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Participant Moved Out of Area",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "2"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Participant Moved Out of Country",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Investigator Decision",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "3"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "2"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Sponsor Decision",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "3"
                                    }
                                ]
                            },
                            {
                                "type": "Non-Compliant With Study Drug",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "1"
                                    }
                                ]
                            },
                            {
                                "type": "Investigator's Discretion",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "2"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Death",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "2"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Hypoglycemic Event",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "4"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG002",
                                        "numSubjects": "0"
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "baselineCharacteristicsModule": {
                "populationDescription": "The randomized set included all participants who were randomized.",
                "groups": [
                    {
                        "id": "BG000",
                        "title": "Glimepiride",
                        "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                    },
                    {
                        "id": "BG001",
                        "title": "TAK-875 25 mg",
                        "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                    },
                    {
                        "id": "BG002",
                        "title": "TAK-875 50 mg",
                        "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                    },
                    {
                        "id": "BG003",
                        "title": "Total",
                        "description": "Total of all reporting groups"
                    }
                ],
                "denoms": [
                    {
                        "units": "Participants",
                        "counts": [
                            {
                                "groupId": "BG000",
                                "value": "824"
                            },
                            {
                                "groupId": "BG001",
                                "value": "817"
                            },
                            {
                                "groupId": "BG002",
                                "value": "813"
                            },
                            {
                                "groupId": "BG003",
                                "value": "2454"
                            }
                        ]
                    }
                ],
                "measures": [
                    {
                        "title": "Age, Continuous",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "years",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "57.3",
                                                "spread": "9.56"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "56.8",
                                                "spread": "9.34"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "56.6",
                                                "spread": "9.81"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "56.9",
                                                "spread": "9.57"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Age, Customized",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Less than (<) 65 years",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "637"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "646"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "648"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1931"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": ">=65 years",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "187"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "171"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "165"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "523"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Sex: Female, Male",
                        "paramType": "COUNT_OF_PARTICIPANTS",
                        "unitOfMeasure": "Participants",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "title": "Female",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "428"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "422"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "362"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1212"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Male",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "396"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "395"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "451"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1242"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Race/Ethnicity, Customized",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Hispanic or Latino",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "68"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "66"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "70"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "204"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Non-Hispanic or Latino",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "105"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "110"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "106"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "321"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Not Available",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "651"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "641"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "637"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1929"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Race/Ethnicity, Customized",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "American Indian or Alaska Native",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "8"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "20"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "40"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Asian",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "101"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "99"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "93"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "293"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Black or African American",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "62"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "70"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "77"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "209"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Native Hawaiian or Other Pacific Islander",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "3"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "4"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "7"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "14"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "White",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "617"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "598"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "601"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1816"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Multiracial",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "33"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "26"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "23"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "82"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Region of Enrollment",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Argentina",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "37"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "39"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "37"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "113"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Australia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "4"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "2"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "3"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "9"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Bulgaria",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "17"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "18"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "16"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "51"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Canada",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "42"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "40"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "39"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "121"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Colombia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "2"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "1"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "3"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Czech Republic",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "31"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "31"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "31"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "93"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Estonia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "36"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Hong Kong",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "9"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "10"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "10"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "29"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Israel",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "50"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "50"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "50"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "150"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Latvia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "15"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "14"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "14"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "43"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Lithuania",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "21"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "23"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "22"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "66"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Malaysia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "17"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "16"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "17"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "50"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Mexico",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "14"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "14"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "15"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "43"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "New Zealand",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "15"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "14"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "15"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "44"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Philippines",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "39"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "38"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "37"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "114"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Poland",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "64"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "66"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "63"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "193"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Romania",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "52"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "52"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "51"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "155"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Russian Federation",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "26"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "26"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "26"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "78"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "South Africa",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "83"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "81"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "83"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "247"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Taiwan, Province Of China",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "11"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "11"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "12"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "34"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Ukraine",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "80"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "80"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "79"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "239"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "United Kingdom",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "18"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "16"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "17"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "51"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "United States",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "165"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "164"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "163"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "492"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Height",
                        "description": "For this outcome measure, number of participants evaluable were 823, 817 and 813 for each arm, respectively.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "centimeter (cm)",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "166.2",
                                                "spread": "10.66"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "166.2",
                                                "spread": "10.23"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "167.3",
                                                "spread": "10.19"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "166.6",
                                                "spread": "10.37"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Weight",
                        "description": "For this outcome measure, number of participants evaluable were 822, 816 and 813 for each arm, respectively.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "kilogram (kg)",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "86.95",
                                                "spread": "18.415"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "87.35",
                                                "spread": "18.283"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "88.37",
                                                "spread": "18.796"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "87.55",
                                                "spread": "18.501"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Body Mass Index (BMI)",
                        "description": "For this outcome measure, number of participants evaluable were 821, 816 and 813 for each arm, respectively.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "kilogram per square meter (kg/m^2)",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "31.34",
                                                "spread": "5.334"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "31.50",
                                                "spread": "5.253"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "31.43",
                                                "spread": "5.403"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "31.42",
                                                "spread": "5.329"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Smoking Classification",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Never smoked",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "552"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "533"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "502"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1587"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Current smoker",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "114"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "143"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "126"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "383"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Ex-smoker",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "158"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "141"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "185"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "484"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Baseline Glycosylated Hemoglobin (HbA1c) Category",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "< 8.5 percent (%)",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "584"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "584"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "592"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "1760"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": ">=8.5%",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "238"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "232"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "221"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "691"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Not Available",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "2"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "1"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "3"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Duration of Diabetes",
                        "description": "For this outcome measure, number of participants evaluable were 823, 817 and 812 for each arm, respectively.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "years",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "6.372",
                                                "spread": "5.293"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "6.566",
                                                "spread": "5.132"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "5.995",
                                                "spread": "4.711"
                                            },
                                            {
                                                "groupId": "BG003",
                                                "value": "6.312",
                                                "spread": "5.056"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "outcomeMeasuresModule": {
                "outcomeMeasures": [
                    {
                        "type": "PRIMARY",
                        "title": "Change From Baseline in HbA1c at Weeks 78 and 104",
                        "description": "The change in the value of HbA1c (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) to be collected at Weeks 78 and 104 relative to baseline.",
                        "populationDescription": "Full Analysis Set (FAS) included all randomized participants who received at least 1 dose of double-blind study medication and who had a baseline and at least 1 post- baseline assessment.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "percentage of glycosylated hemoglobin",
                        "timeFrame": "Baseline and Weeks 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "62"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "61"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "66"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Baseline",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "8.00",
                                                "spread": "0.814"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "8.01",
                                                "spread": "0.777"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "7.99",
                                                "spread": "0.792"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 78",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-0.80",
                                                "spread": "0.957"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.82",
                                                "spread": "0.865"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-0.98",
                                                "spread": "0.834"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 104",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "NA",
                                                "spread": "NA",
                                                "comment": "Data was not reported as none of the participants had data for this arm at this time point."
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-1.03",
                                                "spread": "1.159"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "0.03",
                                                "spread": "0.603"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With Hypoglycemia",
                        "description": "Participants were provided diaries to document any hypoglycemic events that occurred between study visits. Any experience of hypoglycemic signs and symptoms (regardless of the blood glucose value by glucometer) or had a blood glucose value less than or equal to (\\<=) 70 milligram per deciliter (mg/dL) (3.9 millimole per liter (mmol/L) by glucometer (regardless of symptoms) were to be recorded.",
                        "populationDescription": "Safety analysis set included all participants who received at least 1 dose of double-blind study medication. Participants were analyzed according to the study medication they received.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "Day 1 up to Weeks 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "822"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "816"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "813"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Day 1 up to Week 78",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "30.2"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "5.4"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "5.3"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Day 1 up to Week 104",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "30.2"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "5.4"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "5.3"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Day 1 up to Week 78: Odds Ratios, corresponding confidence interval, and p-values were calculated using logistic regression with factors for treatment, country, schedule and baseline HbA1c value.",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "<0.001",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Regression, Logistic",
                                "paramType": "Odds Ratio (OR)",
                                "paramValue": "0.13",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "0.09",
                                "ciUpperLimit": "0.18"
                            },
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG002"
                                ],
                                "groupDescription": "Day 1 up to Week 78: Odds Ratios, corresponding confidence interval, and p-values were calculated using logistic regression with factors for treatment, country, schedule and baseline HbA1c value.",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "<0.001",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Regression, Logistic",
                                "paramType": "Odds Ratio (OR)",
                                "paramValue": "0.13",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "0.09",
                                "ciUpperLimit": "0.18"
                            },
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Day 1 up to Week 104: Odds Ratios, corresponding confidence interval, and p-values were calculated using logistic regression with factors for treatment, country, schedule and baseline HbA1c value.",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "<0.001",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Regression, Logistic",
                                "paramType": "Odds Ratio (OR)",
                                "paramValue": "0.13",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "0.09",
                                "ciUpperLimit": "0.18"
                            },
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG002"
                                ],
                                "groupDescription": "Day 1 up to Week 104: Odds Ratios, corresponding confidence interval, and p-values were calculated using logistic regression with factors for treatment, country, schedule and baseline HbA1c value.",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "<0.001",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Regression, Logistic",
                                "paramType": "Odds Ratio (OR)",
                                "paramValue": "0.13",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "0.09",
                                "ciUpperLimit": "0.18"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change From Baseline in Body Weight at Weeks 78 and 104",
                        "description": "The change between the body weight to be collected at Weeks 78 and 104 relative to baseline.",
                        "populationDescription": "FAS included all randomized participants who received at least 1 dose of double-blind study medication and who had a baseline and at least 1 post- baseline value during the double-blind treatment period. Data for body weight was not available at Week 104 due to early termination of the study.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "kg",
                        "timeFrame": "Baseline and Weeks 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "51"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "44"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "55"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Baseline",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "84.32",
                                                "spread": "0.981"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "84.55",
                                                "spread": "1.003"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "85.67",
                                                "spread": "0.995"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 78",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "1.24",
                                                "spread": "0.492"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.07",
                                                "spread": "0.524"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-0.21",
                                                "spread": "0.487"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Change at Week 78",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "0.065",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Mixed Model Repeated Measures",
                                "statisticalComment": "Treatment, schedule and visit-by-treatment interaction as fixed factors and with baseline value and baseline value by visit interaction as covariates.",
                                "paramType": "Least Squares Mean Difference",
                                "paramValue": "-1.31",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-2.70",
                                "ciUpperLimit": "0.08",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.707"
                            },
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG002"
                                ],
                                "groupDescription": "Change at Week 78",
                                "testedNonInferiority": false,
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "0.034",
                                "pValueComment": "The testing procedure at 2-sided significance level of 0.025 was as follows: 1) TAK-875 25 mg vs. glimepiride, 2) TAK-875 50 mg plus metformin vs. glimepiride. If P-value was not greater than 0.025 at Step 1, then Step 2 was carried out.",
                                "statisticalMethod": "Mixed Model Repeated Measures",
                                "statisticalComment": "Treatment, schedule and visit-by-treatment interaction as fixed factors and with baseline value and baseline value by visit interaction as covariates.",
                                "paramType": "Least Squares Mean Difference",
                                "paramValue": "-1.44",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-2.78",
                                "ciUpperLimit": "-0.11",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.678"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change From Baseline in HbA1c at Weeks 26 and 52",
                        "description": "The change in the value of HbA1c collected at Weeks 26 and 52 relative to baseline.",
                        "populationDescription": "FAS included all randomized participants who received at least 1 dose of double-blind study medication and who had a baseline and at least 1 post- baseline value during the double-blind treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "percentage of glycosylated hemoglobin",
                        "timeFrame": "Baseline and Weeks 26 and 52",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "652"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "645"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "641"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Week 26",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-0.91",
                                                "spread": "0.039"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.63",
                                                "spread": "0.039"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-0.81",
                                                "spread": "0.039"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Week 52",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-0.78",
                                                "spread": "0.043"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.65",
                                                "spread": "0.044"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-0.81",
                                                "spread": "0.043"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With HbA1c <7%",
                        "populationDescription": "FAS included all randomized subjects who received at least 1 dose of double-blind study medication and who had a baseline and at least 1 post- baseline value during the double-blind treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "Weeks 26, 52, 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "652"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "645"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "641"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Week 26",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "51.8"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "38.3"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "48.7"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Week 52",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "47.8"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "43.3"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "54.5"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Week 78",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "45.2"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "37.7"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "54.5"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Week 104",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "NA",
                                                "comment": "Data was not reported as none of the participants had data for this arm at this time point."
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "33.3"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "33.3"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With HbA1c <7% for Participants Who Did Not Report Hypoglycemia",
                        "populationDescription": "Data for this outcome measure was not analyzed as prespecified in the protocol.",
                        "reportingStatus": "POSTED",
                        "timeFrame": "Weeks 26, 52, 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "0"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "0"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "0"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change From Baseline in Fasting Plasma Glucose at Weeks 26, 52, 78 and 104",
                        "description": "The change between the fasting plasma glucose value to be collected at Weeks 26, 52, 78 and 104 relative to baseline.",
                        "populationDescription": "FAS included all randomized participants who received at least 1 dose of double-blind study medication and who had a baseline and at least 1 post- baseline value during the double-blind treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "milligram per deciliter (mg/dL)",
                        "timeFrame": "Baseline and Weeks 26, 52, 78 and 104",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Glimepiride",
                                "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia."
                            },
                            {
                                "id": "OG001",
                                "title": "TAK-875 25 mg",
                                "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            },
                            {
                                "id": "OG002",
                                "title": "TAK-875 50 mg",
                                "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "652"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "816"
                                    },
                                    {
                                        "groupId": "OG002",
                                        "value": "813"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Baseline",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "164.5",
                                                "spread": "41.25"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "165.2",
                                                "spread": "38.45"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "163.7",
                                                "spread": "38.65"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 26",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-19.5",
                                                "spread": "41.90"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-17.4",
                                                "spread": "34.67"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-23.0",
                                                "spread": "31.99"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 52",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-19.8",
                                                "spread": "40.81"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-19.3",
                                                "spread": "36.85"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-23.7",
                                                "spread": "33.78"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 78",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "0.0",
                                                "spread": "41.87"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-17.6",
                                                "spread": "30.03"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-21.4",
                                                "spread": "41.27"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Change at Week 104",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "NA",
                                                "spread": "NA",
                                                "comment": "Data was not reported as none of the participants had data for this arm at this time point."
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-24.0",
                                                "spread": "1.41"
                                            },
                                            {
                                                "groupId": "OG002",
                                                "value": "-32.0",
                                                "spread": "17.58"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "adverseEventsModule": {
                "frequencyThreshold": "2",
                "timeFrame": "Treatment-emergent adverse events are adverse events started after first dose of study drug and no more than 30 days for a serious adverse event after the last dose of study drug. Time of individual participant follow-up ranged from 1 to 735 days.",
                "description": "At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.",
                "eventGroups": [
                    {
                        "id": "EG000",
                        "title": "Glimepiride",
                        "description": "TAK-875 placebo-matching tablets, orally, once daily and glimepiride 1 mg, over-encapsulated capsules, orally, once daily for 1 week followed by up-titration in 2 mg increments up to 6 mg, orally, once daily along with metformin greater than or equal to (\\>=)1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks. Glimepiride dose could be down-titrated from 6 mg in case of recurrent or severe hypoglycemia.",
                        "seriousNumAffected": 63,
                        "seriousNumAtRisk": 822,
                        "otherNumAffected": 334,
                        "otherNumAtRisk": 822
                    },
                    {
                        "id": "EG001",
                        "title": "TAK-875 25 mg",
                        "description": "TAK-875 25 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks.",
                        "seriousNumAffected": 41,
                        "seriousNumAtRisk": 816,
                        "otherNumAffected": 337,
                        "otherNumAtRisk": 816
                    },
                    {
                        "id": "EG002",
                        "title": "TAK-875 50 mg",
                        "description": "TAK-875 50 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily along with metformin \\>=1500 mg per day or maximum tolerated dose, tablets, orally for up to 104 weeks.",
                        "seriousNumAffected": 58,
                        "seriousNumAtRisk": 813,
                        "otherNumAffected": 323,
                        "otherNumAtRisk": 813
                    }
                ],
                "seriousEvents": [
                    {
                        "term": "Retinal haemorrhage",
                        "organSystem": "Eye disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Ventricular extrasystoles",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Palpitations",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Atrioventricular block first degree",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Bundle branch block right",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cardiomyopathy",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Ischaemic cardiomyopathy",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Coronary artery disease",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Coronary artery occlusion",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cardiac failure congestive",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cardiac failure",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cardiac failure acute",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Angina unstable",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 4,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Myocardial infarction",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Acute myocardial infarction",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Acute coronary syndrome",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Atrial fibrillation",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 5,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Atrial flutter",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 2,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Supraventricular tachycardia",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cardiac arrest",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Meniere's disease",
                        "organSystem": "Ear and labyrinth disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Vertigo",
                        "organSystem": "Ear and labyrinth disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cataract",
                        "organSystem": "Eye disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Retinal artery thrombosis",
                        "organSystem": "Eye disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Lumbar hernia",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Abdominal hernia obstructive",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pancreatitis acute",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Intestinal polyp haemorrhage",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Gastritis",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Abdominal pain",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Gastrooesophageal reflux disease",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Haemorrhoids",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Megacolon",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Gastrointestinal haemorrhage",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Oesophagitis",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Umbilical hernia, obstructive",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Death",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Sudden death",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Chest pain",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 3,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 2,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 3,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Chest discomfort",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Non-cardiac chest pain",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cholelithiasis",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cholecystitis acute",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cholecystitis chronic",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Jaundice",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hepatic failure",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hepatitis",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hepatitis toxic",
                        "organSystem": "Hepatobiliary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Gastroenteritis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 4,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Appendicitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Peritonitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cellulitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Abscess oral",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Otitis media chronic",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Dengue fever",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Keratitis fungal",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Liver abscess",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Groin abscess",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pneumonia",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 3,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 3,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Bronchitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Sepsis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Tonsillitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pyelonephritis acute",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Urinary tract infection",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Subdural haematoma",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Meniscus injury",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Femur fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hip fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Tibia fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Tendon rupture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Fall",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Post procedural complication",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Contusion",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Radius fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Ejection fraction decreased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Prostatic specific antigen increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Amylase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Lipase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Alanine aminotransferase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Aspartate aminotransferase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hepatic enzyme increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Liver function test abnormal",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Blood creatinine increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Obesity",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hyperglycaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hypoglycaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hypokalaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Osteochondrosis",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Intervertebral disc degeneration",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Intervertebral disc protrusion",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Joint swelling",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Back pain",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Musculoskeletal chest pain",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Musculoskeletal pain",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Neck pain",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Myopathy",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Spinal osteoarthritis",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Colon cancer",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Linitis plastica",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hepatic cancer metastatic",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Kaposi's sarcoma",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Neoplasm",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pancreatic carcinoma",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Clear cell renal cell carcinoma",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Small cell lung cancer",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Basal cell carcinoma",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Thyroid cancer",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Uterine cancer",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cerebrovascular accident",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Ischaemic stroke",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Malignant melanoma",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 2,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Brain stem infarction",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cerebral haemorrhage",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Carotid artery stenosis",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Syncope",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Paraesthesia",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Epilepsy",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Schizophrenia",
                        "organSystem": "Psychiatric disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Transient ischaemic attack",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Renal failure",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Renal failure acute",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Nephrolithiasis",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Urethral stenosis",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Haematuria",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Calculus ureteric",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Renal colic",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cervical polyp",
                        "organSystem": "Reproductive system and breast disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Menorrhagia",
                        "organSystem": "Reproductive system and breast disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Uterine prolapse",
                        "organSystem": "Reproductive system and breast disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Uterovaginal prolapse",
                        "organSystem": "Reproductive system and breast disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Uterine polyp",
                        "organSystem": "Reproductive system and breast disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Sleep apnoea syndrome",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Chronic obstructive pulmonary disease",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Asthma",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pulmonary hypertension",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Coronary artery bypass",
                        "organSystem": "Surgical and medical procedures",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hypertensive crisis",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Deep vein thrombosis",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Peripheral vascular disorder",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Intermittent claudication",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 0,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Peripheral ischaemia",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 1,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hypertension",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 2,
                                "numAtRisk": 813
                            }
                        ]
                    }
                ],
                "otherEvents": [
                    {
                        "term": "Diarrhoea",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 28,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 35,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 36,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Blood creatine phosphokinase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 26,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 15,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 17,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Dizziness",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 20,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 16,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 9,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Nausea",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 18,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 18,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 16,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pain in extremity",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 20,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 13,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 14,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Cough",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 24,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 26,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 16,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Urinary tract infection",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 28,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 22,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 29,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Bronchitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 25,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 22,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 25,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Headache",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 47,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 42,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 34,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Pharyngitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 16,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 10,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 17,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Nasopharyngitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 44,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 38,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 45,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Upper respiratory tract infection",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 55,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 73,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 59,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Influenza",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 38,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 31,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 31,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hypertension",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 47,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 28,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 26,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Arthralgia",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 29,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 28,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 22,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Alanine aminotransferase increased",
                        "organSystem": "Investigations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 17,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 22,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 24,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Hyperuricaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 19,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 12,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 15,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Fatigue",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 10,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 6,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 17,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Dyslipidaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 15,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 10,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 17,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Gastroenteritis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 11,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 12,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 17,
                                "numAtRisk": 813
                            }
                        ]
                    },
                    {
                        "term": "Back pain",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA (16.1)",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 31,
                                "numAtRisk": 822
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 33,
                                "numAtRisk": 816
                            },
                            {
                                "groupId": "EG002",
                                "numAffected": 29,
                                "numAtRisk": 813
                            }
                        ]
                    }
                ]
            },
            "moreInfoModule": {
                "certainAgreement": {
                    "piSponsorEmployee": false,
                    "restrictionType": "OTHER",
                    "restrictiveAgreement": true,
                    "otherDetails": "The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property."
                },
                "pointOfContact": {
                    "title": "Medical Director",
                    "organization": "Takeda",
                    "email": "clinicaltrialregistry@tpna.com",
                    "phone": "+1-877-825-3327"
                }
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2025-09-19",
                "removedCountries": [
                    "Brazil",
                    "France",
                    "Germany",
                    "India"
                ]
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D003924",
                        "term": "Diabetes Mellitus, Type 2"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D009750",
                        "term": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "id": "D004700",
                        "term": "Endocrine System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "C557331",
                        "term": "TAK-875"
                    },
                    {
                        "id": "C057619",
                        "term": "glimepiride"
                    }
                ]
            }
        },
        "hasResults": true
    },
    {
        "protocolSection": {
            "identificationModule": {
                "nctId": "NCT01798706",
                "orgStudyIdInfo": {
                    "id": "EFC12703"
                },
                "secondaryIdInfos": [
                    {
                        "id": "2012-003292-19",
                        "type": "EUDRACT_NUMBER"
                    },
                    {
                        "id": "U1111-1132-9156",
                        "type": "OTHER",
                        "domain": "UTN"
                    }
                ],
                "organization": {
                    "fullName": "Sanofi",
                    "class": "INDUSTRY"
                },
                "briefTitle": "Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients",
                "officialTitle": "A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter, 24 Week Study Assessing the Safety and Efficacy of Lixisenatide in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Diabetes Treatment Regimen",
                "acronym": "GetGoal-O"
            },
            "statusModule": {
                "statusVerifiedDate": "2017-03",
                "overallStatus": "COMPLETED",
                "expandedAccessInfo": {
                    "hasExpandedAccess": false
                },
                "startDateStruct": {
                    "date": "2013-06"
                },
                "primaryCompletionDateStruct": {
                    "date": "2015-02",
                    "type": "ACTUAL"
                },
                "completionDateStruct": {
                    "date": "2015-02",
                    "type": "ACTUAL"
                },
                "studyFirstSubmitDate": "2013-02-22",
                "studyFirstSubmitQcDate": "2013-02-22",
                "studyFirstPostDateStruct": {
                    "date": "2013-02-26",
                    "type": "ESTIMATED"
                },
                "resultsFirstSubmitDate": "2016-08-22",
                "resultsFirstSubmitQcDate": "2016-08-22",
                "resultsFirstPostDateStruct": {
                    "date": "2016-10-14",
                    "type": "ESTIMATED"
                },
                "dispFirstSubmitDate": "2016-02-11",
                "dispFirstSubmitQcDate": "2016-02-11",
                "dispFirstPostDateStruct": {
                    "date": "2016-03-14",
                    "type": "ESTIMATED"
                },
                "lastUpdateSubmitDate": "2017-03-21",
                "lastUpdatePostDateStruct": {
                    "date": "2017-04-18",
                    "type": "ACTUAL"
                }
            },
            "sponsorCollaboratorsModule": {
                "responsibleParty": {
                    "type": "SPONSOR"
                },
                "leadSponsor": {
                    "name": "Sanofi",
                    "class": "INDUSTRY"
                }
            },
            "oversightModule": {
                "oversightHasDmc": true
            },
            "descriptionModule": {
                "briefSummary": "Primary objective:\n\n\\- To evaluate the effect of lixisenatide versus placebo over a period of 24 weeks on glycemic control, as evaluated by glycosylated hemoglobin (HbA1c) reduction, in older type 2 diabetes participants (T2DM) who are inadequately controlled with their current anti-diabetic treatment regimen.\n\nMain secondary objective:\n\n\\- To assess the safety and tolerability of lixisenatide compared to placebo in older T2DM participants (including occurrence of documented (Plasma Glucose PG \\< 60 mg/dL) symptomatic hypoglycemia and gastrointestinal side effects).\n\nOther secondary objectives:\n\n* To assess the effect of lixisenatide compared to placebo after 24-week treatment on:\n\n  * Fasting plasma glucose (FPG);\n  * During liquid standardized breakfast meal challenge test : 2 hour- Postprandial Plasma Glucose (PPG) and Plasma Glucose Excursion;\n  * 7-point Self-monitored plasma glucose (SMPG) profile;\n  * Body weight;\n  * Change in total daily dose of basal insulin (if taken);\n  * Percentage of participants requiring rescue therapy\n  * Safety and tolerability;\n* To assess lixisenatide pharmacokinetic profile;\n* To assess anti-lixisenatide antibody development.",
                "detailedDescription": "Approximately 31 weeks including 24 week treatment period."
            },
            "conditionsModule": {
                "conditions": [
                    "Type 2 Diabetes"
                ]
            },
            "designModule": {
                "studyType": "INTERVENTIONAL",
                "phases": [
                    "PHASE3"
                ],
                "designInfo": {
                    "allocation": "RANDOMIZED",
                    "interventionModel": "PARALLEL",
                    "primaryPurpose": "TREATMENT",
                    "maskingInfo": {
                        "masking": "QUADRUPLE",
                        "whoMasked": [
                            "PARTICIPANT",
                            "CARE_PROVIDER",
                            "INVESTIGATOR",
                            "OUTCOMES_ASSESSOR"
                        ]
                    }
                },
                "enrollmentInfo": {
                    "count": 350,
                    "type": "ACTUAL"
                }
            },
            "armsInterventionsModule": {
                "armGroups": [
                    {
                        "label": "Lixisenatide",
                        "type": "EXPERIMENTAL",
                        "description": "Lixisenatide 10 mcg once daily (QD) for 2 weeks, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg.",
                        "interventionNames": [
                            "Drug: Lixisenatide (AVE0010)",
                            "Drug: Antidiabetic background therapy"
                        ]
                    },
                    {
                        "label": "Placebo",
                        "type": "PLACEBO_COMPARATOR",
                        "description": "Placebo (matched to lixisenatide) QD for 24 Weeks.",
                        "interventionNames": [
                            "Drug: Placebo",
                            "Drug: Antidiabetic background therapy"
                        ]
                    }
                ],
                "interventions": [
                    {
                        "type": "DRUG",
                        "name": "Lixisenatide (AVE0010)",
                        "description": "Pharmaceutical form: Solution for injection in pre-filled pen administered 30 to 60 minutes before breakfast in the morning\n\nRoute of administration: Subcutaneous injection",
                        "armGroupLabels": [
                            "Lixisenatide"
                        ],
                        "otherNames": [
                            "Lyxumia"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Placebo",
                        "description": "Pharmaceutical form: Solution for injection in pre-filled pen administered 30 to 60 minutes before breakfast in the morning\n\nRoute of administration: Subcutaneous injection",
                        "armGroupLabels": [
                            "Placebo"
                        ]
                    },
                    {
                        "type": "DRUG",
                        "name": "Antidiabetic background therapy",
                        "description": "Participants received a stable regimen of anti-diabetic background therapy for at least 3 months prior to screening, during the placebo run-in period and the 24 week treatment period. Allowed background antidiabetic therapy included metformin, sulfonylurea (except glibenclamide \\>10 mg, gliclazide \\>160 mg), meglitinides (except repaglinide \\>6 mg), pioglitazone and basal insulin. Insulin glargine, neutral protamine hagedorn (NPH) insulin, detemir, lente and ultralente were considered as basal insulin.",
                        "armGroupLabels": [
                            "Lixisenatide",
                            "Placebo"
                        ]
                    }
                ]
            },
            "outcomesModule": {
                "primaryOutcomes": [
                    {
                        "measure": "Absolute Change in HbA1c From Baseline to Week 24",
                        "description": "Change in HbA1c was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using last on-treatment observation carried forward (LOCF). On-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to 14 days after the last dose of study drug. Here, number of participants analyzed=participants with baseline and at least one post-baseline HbA1c assessment during on-treatment period.",
                        "timeFrame": "Baseline, Week 24"
                    }
                ],
                "secondaryOutcomes": [
                    {
                        "measure": "Change in 2-Hour PPG From Baseline to Week 24",
                        "description": "The 2-hour PPG test measured blood glucose 2 hours after eating a liquid standardized breakfast meal. Change in PPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Change in Average 7-point SMPG Profiles From Baseline to Week 24",
                        "description": "Participants recorded a 7-point plasma glucose profile measured before and 2 hours after each meal and at bedtime three times in a week before baseline, before visit Week 12 and before visit week 26 and the average value across the profiles performed in the week a visit for the 7-time points was calculated. Change in average 7-point SMPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to the day of last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Change in Body Weight From Baseline to Week 24",
                        "description": "Change in body weight was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. On-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to 3 days after the last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Change in FPG From Baseline to Week 24",
                        "description": "Change in FPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to 1 day after the last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Percentage of Participants Requiring Rescue Therapy During 24 Week Treatment Period",
                        "description": "Routine fasting SMPG and central laboratory FPG (and HbA1c after Week 12) values were used to determine the requirement of rescue medication. If fasting SMPG value exceeded the specified limit for 3 consecutive days, the central laboratory FPG (and HbA1c after Week 12) were performed. Threshold values - from baseline to Week 8: fasting SMPG/FPG \\>270 mg/dL (15.0 mmol/L), from Week 8 to Week 12: fasting SMPG/FPG \\>240 mg/dL (13.3 mmol/L), and from Week 12 to Week 24: fasting SMPG/FPG \\>200 mg/dL (11.1 mmol/L) or HbA1c \\>9%.",
                        "timeFrame": "Baseline up to Week 24"
                    },
                    {
                        "measure": "Change in Plasma Glucose Excursions From Baseline to Week 24",
                        "description": "Plasma glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the liquid standardized breakfast meal test, before study drug administration. Change in plasma glucose excursions were calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Change in Total Daily Basal Insulin Dose From Baseline to Week 24 (in Participants Who Took Basal Insulin as Background Therapy)",
                        "description": "Change in basal insulin dose was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "timeFrame": "Baseline, Week 24"
                    },
                    {
                        "measure": "Percentage of Participants With Symptomatic and Severe Symptomatic Hypoglycemia",
                        "description": "Symptomatic hypoglycemia was an event with clinical symptoms that were considered to result from a hypoglycemic episode with an accompanying plasma glucose less than 60 mg/dL (3.3 mmol/L) or associated with prompt recovery after oral carbohydrate, intravenous glucose, or glucagon administration if no plasma glucose measurement was available. Severe symptomatic hypoglycemia was symptomatic hypoglycemia event in which the participant required the assistance of another person and was associated with either a plasma glucose level below 36 mg/dL (2.0 mmol/L) or prompt recovery after oral carbohydrate, intravenous glucose, or glucagon administration, if no plasma glucose measurement was available.",
                        "timeFrame": "First dose of study drug up to 3 days after the last dose administration (maximum of 171 days)"
                    },
                    {
                        "measure": "Percentage of Participants With HbA1c Reduction >0.5% at Week 24 and Did Not Experienced Documented (Plasma Glucose <60 mg/dL) Symptomatic Hypoglycemia",
                        "description": "The on-treatment period for HbA1c assessment was defined as the time from the first dose of study drug up to 14 days after the last dose of study drug. The on-treatment period for symptomatic hypoglycemia assessment was defined as the time from the first dose of study drug up to 1 day after the last dose of study drug.",
                        "timeFrame": "Week 24"
                    },
                    {
                        "measure": "Percentage of Participants With Gastrointestinal Disorders",
                        "timeFrame": "Up to Day 171"
                    }
                ]
            },
            "eligibilityModule": {
                "eligibilityCriteria": "Inclusion criteria :\n\n* Older participants, aged 70 years and above, with T2DM inadequately controlled on their current anti-diabetic pharmaceutical treatment regimen.\n* Signed written informed consent.\n\nExclusion criteria:\n\n* At screening HbA1c \u22647.0% or \\>10% (Acknowledging that the threshold of 7% may not be appropriate for all older participants and that this was the responsibility of the investigator to include the participant based on an individual evaluation of the expected benefits of better glycemic control versus risk of hypoglycemia).\n* At screening participants on both basal insulin and sulfonylurea or basal insulin and meglitinides.\n* At screening FPG \\>250 mg/dL (\\>13.9 mmol/L).\n* Type 1 diabetes mellitus or history of ketoacidosis within one year prior to the screening visit.\n* Type 2 diabetes mellitus diagnosed less than 1 year prior to screening.\n* Anti-diabetic treatment not at a stable regimen or initiated within the last 3 months prior to screening.\n* Treatment within the 3 months preceding the screening with other anti-diabetic agent than allowed background therapy. Allowed therapy includes metformin, sulfonylurea (except glibenclamide \\>10mg, gliclazide \\>160mg), meglitinides (except repaglinide \\>6mg), pioglitazone and basal insulin and should follow local product circulars and labeling restrictions for the study population.\n* Participants who had been on an approved or an investigational Glucagon-like peptide 1 (GLP-1) medication (exenatide, liraglutide, lixisenatide or others).\n* History of severe hypoglycemia associated with symptoms unawareness or results in unconsciousness/coma/seizure in the 6 months prior to screening.\n* BMI \\<22 or \\>40 kg/m\\^2.\n* Malnutrition assessed clinically by the investigator or any sub-investigator and by Mini-Nutritional Assessment-Short Form (MNA-SF) score \\<12 in countries (the judgment of the investigator prevails on questionnaires scores).\n* Cognitive disorder and dementia assessed clinically by the investigator or any sub investigator and by Mini Mental State Examination (MMSE) score \\<24 (the judgment of the investigator prevails on questionnaires scores), or any neurologic disorder that affected the participant's ability to participate in the study.\n* Participant who had a glomerular filtration rate (eGFR) (using the Modification of Diet in Renal Disease (MDRD) formula \\<30ml/min/1.73m\\^2).\n* Participant with severe or uncontrolled disease, or any clinically significant abnormality identified on physical examination or investigational clinical procedure that, in the judgment of the investigator or any sub-investigator, would preclude safe completion of the study or constrains efficacy assessment.\n* Laboratory findings at the time of screening:\n\n  * Amylase and/or lipase: \\>3 times the upper limit of the normal (ULN) laboratory range\n  * Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \\>3 times ULN\n  * Calcitonin \\>20 pg/mL (5.9 pmol/L).\n* Clinically relevant history of gastrointestinal disease associated with prolonged nausea and vomiting, including (but not limited to): gastroparesis, unstable (i.e. worsening) and not controlled (i.e. prolonged nausea and vomiting) gastroesophageal reflux disease within 6 months prior to screening.\n* History of unexplained pancreatitis, chronic pancreatitis, pancreatectomy, stomach/gastric surgery, inflammatory bowel disease.\n* Personal or immediate family history of medullary thyroid cancer or genetic conditions that predisposed to medullary thyroid cancer (e.g., multiple endocrine neoplasia syndromes).\n\nThe above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.",
                "healthyVolunteers": false,
                "sex": "ALL",
                "minimumAge": "70 Years",
                "stdAges": [
                    "OLDER_ADULT"
                ]
            },
            "contactsLocationsModule": {
                "overallOfficials": [
                    {
                        "name": "Clinical Sciences & Operations",
                        "affiliation": "Sanofi",
                        "role": "STUDY_DIRECTOR"
                    }
                ],
                "locations": [
                    {
                        "facility": "Investigational Site Number 840010",
                        "city": "La Jolla",
                        "state": "California",
                        "zip": "92037",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 32.84727,
                            "lon": -117.2742
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840015",
                        "city": "Norwalk",
                        "state": "California",
                        "zip": "90650",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 33.90224,
                            "lon": -118.08173
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840003",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33156",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840012",
                        "city": "Miami",
                        "state": "Florida",
                        "zip": "33156",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 25.77427,
                            "lon": -80.19366
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840002",
                        "city": "Des Moines",
                        "state": "Iowa",
                        "zip": "50314",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.60054,
                            "lon": -93.60911
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840008",
                        "city": "Oxon Hill",
                        "state": "Maryland",
                        "zip": "20745",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 38.80345,
                            "lon": -76.9897
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840004",
                        "city": "Rockville",
                        "state": "Maryland",
                        "zip": "20852",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 39.084,
                            "lon": -77.15276
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840017",
                        "city": "Biloxi",
                        "state": "Mississippi",
                        "zip": "39531",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 30.39603,
                            "lon": -88.88531
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840009",
                        "city": "Omaha",
                        "state": "Nebraska",
                        "zip": "68131",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 41.25626,
                            "lon": -95.94043
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840016",
                        "city": "Salisbury",
                        "state": "North Carolina",
                        "zip": "28144",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 35.67097,
                            "lon": -80.47423
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840006",
                        "city": "Fargo",
                        "state": "North Dakota",
                        "zip": "58103",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 46.87719,
                            "lon": -96.7898
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840014",
                        "city": "Canal Fulton",
                        "state": "Ohio",
                        "zip": "44614",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 40.88978,
                            "lon": -81.59762
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840011",
                        "city": "St. George",
                        "state": "Utah",
                        "zip": "84790",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 37.10415,
                            "lon": -113.58412
                        }
                    },
                    {
                        "facility": "Investigational Site Number 840007",
                        "city": "Milwaukee",
                        "state": "Wisconsin",
                        "zip": "53209",
                        "country": "United States",
                        "geoPoint": {
                            "lat": 43.0389,
                            "lon": -87.90647
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036002",
                        "city": "Box Hill",
                        "zip": "3128",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -37.81887,
                            "lon": 145.12545
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036006",
                        "city": "Brookvale",
                        "zip": "2100",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.76108,
                            "lon": 151.27446
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036004",
                        "city": "Camperdown",
                        "zip": "2050",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.88965,
                            "lon": 151.17642
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036005",
                        "city": "Gosford",
                        "zip": "2250",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -33.4244,
                            "lon": 151.34399
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036001",
                        "city": "Heidelberg",
                        "zip": "3081",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -37.75,
                            "lon": 145.06667
                        }
                    },
                    {
                        "facility": "Investigational Site Number 036003",
                        "city": "Parkville",
                        "zip": "3050",
                        "country": "Australia",
                        "geoPoint": {
                            "lat": -37.78333,
                            "lon": 144.95
                        }
                    },
                    {
                        "facility": "Investigational Site Number 100002",
                        "city": "Plovdiv",
                        "zip": "4002",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.15387,
                            "lon": 24.75001
                        }
                    },
                    {
                        "facility": "Investigational Site Number 100005",
                        "city": "Plovdiv",
                        "zip": "4002",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.15387,
                            "lon": 24.75001
                        }
                    },
                    {
                        "facility": "Investigational Site Number 100003",
                        "city": "Sofia",
                        "zip": "1632",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.69751,
                            "lon": 23.32415
                        }
                    },
                    {
                        "facility": "Investigational Site Number 100004",
                        "city": "Stara Zagora",
                        "zip": "6000",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 42.43205,
                            "lon": 25.64262
                        }
                    },
                    {
                        "facility": "Investigational Site Number 100001",
                        "city": "Varna",
                        "zip": "9000",
                        "country": "Bulgaria",
                        "geoPoint": {
                            "lat": 43.21912,
                            "lon": 27.91024
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124003",
                        "city": "Hamilton",
                        "zip": "L8L 5G8",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 43.25011,
                            "lon": -79.84963
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124007",
                        "city": "London",
                        "zip": "N6B 2E3",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 42.98339,
                            "lon": -81.23304
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124001",
                        "city": "Saint Romuald",
                        "zip": "G6W 5M6",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 46.75818,
                            "lon": -71.23921
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124002",
                        "city": "Sherbrooke",
                        "zip": "J1H 5N4",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.40008,
                            "lon": -71.89908
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124005",
                        "city": "Vancouver",
                        "zip": "V5Z 1M9",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 49.24966,
                            "lon": -123.11934
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124006",
                        "city": "Vancouver",
                        "zip": "V5Z 1M9",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 49.24966,
                            "lon": -123.11934
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124008",
                        "city": "Westmount",
                        "zip": "H3Z 1E5",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 45.48341,
                            "lon": -73.59918
                        }
                    },
                    {
                        "facility": "Investigational Site Number 124004",
                        "city": "Winnipeg",
                        "zip": "R3E 3P4",
                        "country": "Canada",
                        "geoPoint": {
                            "lat": 49.8844,
                            "lon": -97.14704
                        }
                    },
                    {
                        "facility": "Investigational Site Number 208005",
                        "city": "Esbjerg",
                        "zip": "6700",
                        "country": "Denmark",
                        "geoPoint": {
                            "lat": 55.47028,
                            "lon": 8.45187
                        }
                    },
                    {
                        "facility": "Investigational Site Number 208001",
                        "city": "K\u00f8benhavn NV",
                        "zip": "2400",
                        "country": "Denmark",
                        "geoPoint": {
                            "lat": 55.71258,
                            "lon": 12.52343
                        }
                    },
                    {
                        "facility": "Investigational Site Number 208004",
                        "city": "K\u00f8benhavn S",
                        "zip": "2300",
                        "country": "Denmark",
                        "geoPoint": {
                            "lat": 55.65059,
                            "lon": 12.5978
                        }
                    },
                    {
                        "facility": "Investigational Site Number 208002",
                        "city": "Slagelse",
                        "zip": "4200",
                        "country": "Denmark",
                        "geoPoint": {
                            "lat": 55.40276,
                            "lon": 11.35459
                        }
                    },
                    {
                        "facility": "Investigational Site Number 208003",
                        "city": "Svendborg",
                        "zip": "5700",
                        "country": "Denmark",
                        "geoPoint": {
                            "lat": 55.05982,
                            "lon": 10.60677
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276005",
                        "city": "Dresden",
                        "zip": "01307",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 51.05089,
                            "lon": 13.73832
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276004",
                        "city": "Essen",
                        "zip": "45359",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 51.45657,
                            "lon": 7.01228
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276002",
                        "city": "M\u00fcnchen",
                        "zip": "80639",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 51.60698,
                            "lon": 13.31243
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276001",
                        "city": "M\u00fcnster",
                        "zip": "48145",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 51.96236,
                            "lon": 7.62571
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276006",
                        "city": "Pirna",
                        "zip": "01796",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 50.95843,
                            "lon": 13.93702
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276007",
                        "city": "Pohlheim",
                        "zip": "35415",
                        "country": "Germany"
                    },
                    {
                        "facility": "Investigational Site Number 276008",
                        "city": "Potsdam",
                        "zip": "14469",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 52.39886,
                            "lon": 13.06566
                        }
                    },
                    {
                        "facility": "Investigational Site Number 276003",
                        "city": "Saarlouis",
                        "zip": "66740",
                        "country": "Germany",
                        "geoPoint": {
                            "lat": 49.31366,
                            "lon": 6.75154
                        }
                    },
                    {
                        "facility": "Investigational Site Number 578001",
                        "city": "H\u00f8nefoss",
                        "zip": "3515",
                        "country": "Norway",
                        "geoPoint": {
                            "lat": 60.16804,
                            "lon": 10.25647
                        }
                    },
                    {
                        "facility": "Investigational Site Number 578005",
                        "city": "Kongsvinger",
                        "zip": "2212",
                        "country": "Norway",
                        "geoPoint": {
                            "lat": 60.19049,
                            "lon": 11.99772
                        }
                    },
                    {
                        "facility": "Investigational Site Number 578003",
                        "city": "Oslo",
                        "country": "Norway",
                        "geoPoint": {
                            "lat": 59.91273,
                            "lon": 10.74609
                        }
                    },
                    {
                        "facility": "Investigational Site Number 578006",
                        "city": "Stavanger",
                        "zip": "4095",
                        "country": "Norway",
                        "geoPoint": {
                            "lat": 58.97005,
                            "lon": 5.73332
                        }
                    },
                    {
                        "facility": "Investigational Site Number 578004",
                        "city": "Trondheim",
                        "zip": "7012",
                        "country": "Norway",
                        "geoPoint": {
                            "lat": 63.43049,
                            "lon": 10.39506
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604001",
                        "city": "Arequipa",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -16.39899,
                            "lon": -71.53747
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604011",
                        "city": "Lima",
                        "zip": "27",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604005",
                        "city": "Lima",
                        "zip": "LIMA 10",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604003",
                        "city": "Lima",
                        "zip": "LIMA 14",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604006",
                        "city": "Lima",
                        "zip": "LIMA 31",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604002",
                        "city": "Lima",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604007",
                        "city": "Lima",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -12.04318,
                            "lon": -77.02824
                        }
                    },
                    {
                        "facility": "Investigational Site Number 604008",
                        "city": "Piura",
                        "country": "Peru",
                        "geoPoint": {
                            "lat": -5.18192,
                            "lon": -80.65715
                        }
                    },
                    {
                        "facility": "Investigational Site Number 616004",
                        "city": "Gdansk",
                        "zip": "80-858",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 54.35227,
                            "lon": 18.64912
                        }
                    },
                    {
                        "facility": "Investigational Site Number 616003",
                        "city": "Krakow",
                        "zip": "31-024",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.06143,
                            "lon": 19.93658
                        }
                    },
                    {
                        "facility": "Investigational Site Number 616001",
                        "city": "Poznan",
                        "zip": "61-665",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 52.40692,
                            "lon": 16.92993
                        }
                    },
                    {
                        "facility": "Investigational Site Number 616002",
                        "city": "Ruda \u015al\u0105ska",
                        "zip": "41-709",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 50.2584,
                            "lon": 18.85632
                        }
                    },
                    {
                        "facility": "Investigational Site Number 616006",
                        "city": "Szczecin",
                        "zip": "70-506",
                        "country": "Poland",
                        "geoPoint": {
                            "lat": 53.42894,
                            "lon": 14.55302
                        }
                    },
                    {
                        "facility": "Investigational Site Number 710003",
                        "city": "Cape Town",
                        "zip": "7500",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.92584,
                            "lon": 18.42322
                        }
                    },
                    {
                        "facility": "Investigational Site Number 710002",
                        "city": "Cape Town",
                        "zip": "7530",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -33.92584,
                            "lon": 18.42322
                        }
                    },
                    {
                        "facility": "Investigational Site Number 710004",
                        "city": "Somerset West",
                        "zip": "7130",
                        "country": "South Africa",
                        "geoPoint": {
                            "lat": -34.08401,
                            "lon": 18.82113
                        }
                    },
                    {
                        "facility": "Investigational Site Number 724001",
                        "city": "Alzira",
                        "zip": "46600",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 39.15,
                            "lon": -0.43333
                        }
                    },
                    {
                        "facility": "Investigational Site Number 724005",
                        "city": "Barcelona",
                        "zip": "08035",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 41.38879,
                            "lon": 2.15899
                        }
                    },
                    {
                        "facility": "Investigational Site Number 724006",
                        "city": "Hostalets de Baleny\u00e0",
                        "zip": "08550",
                        "country": "Spain"
                    },
                    {
                        "facility": "Investigational Site Number 724003",
                        "city": "Madrid",
                        "zip": "28046",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 40.4165,
                            "lon": -3.70256
                        }
                    },
                    {
                        "facility": "Investigational Site Number 724002",
                        "city": "Sanl\u00facar de Barrameda",
                        "zip": "11540",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 36.77808,
                            "lon": -6.3515
                        }
                    },
                    {
                        "facility": "Investigational Site Number 724004",
                        "city": "Santiago de Compostela",
                        "zip": "15706",
                        "country": "Spain",
                        "geoPoint": {
                            "lat": 42.88052,
                            "lon": -8.54569
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752006",
                        "city": "Gothenburg",
                        "zip": "405 45",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 57.70716,
                            "lon": 11.96679
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752007",
                        "city": "H\u00e4rn\u00f6sand",
                        "zip": "871 82",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 62.63228,
                            "lon": 17.93794
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752002",
                        "city": "Lund",
                        "zip": "22221",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 55.70584,
                            "lon": 13.19321
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752004",
                        "city": "Malmo",
                        "zip": "211 52",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 55.60587,
                            "lon": 13.00073
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752003",
                        "city": "Stockholm",
                        "zip": "111 57",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 59.32938,
                            "lon": 18.06871
                        }
                    },
                    {
                        "facility": "Investigational Site Number 752001",
                        "city": "Stockholm",
                        "zip": "171 76",
                        "country": "Sweden",
                        "geoPoint": {
                            "lat": 59.32938,
                            "lon": 18.06871
                        }
                    },
                    {
                        "facility": "Investigational Site Number 826003",
                        "city": "Bexhill-on-Sea",
                        "zip": "TN39 4SP",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 50.85023,
                            "lon": 0.47095
                        }
                    },
                    {
                        "facility": "Investigational Site Number 826001",
                        "city": "Glasgow",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 55.86515,
                            "lon": -4.25763
                        }
                    },
                    {
                        "facility": "Investigational Site Number 826002",
                        "city": "Irvine",
                        "zip": "KA12 0AY",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 55.6194,
                            "lon": -4.65508
                        }
                    },
                    {
                        "facility": "Investigational Site Number 826004",
                        "city": "Trowbridge",
                        "zip": "BA14 8QA",
                        "country": "United Kingdom",
                        "geoPoint": {
                            "lat": 51.31889,
                            "lon": -2.20861
                        }
                    }
                ]
            },
            "referencesModule": {
                "references": [
                    {
                        "pmid": "28188240",
                        "type": "RESULT",
                        "citation": "Meneilly GS, Roy-Duval C, Alawi H, Dailey G, Bellido D, Trescoli C, Manrique Hurtado H, Guo H, Pilorget V, Perfetti R, Simpson H; GetGoal-O Trial Investigators. Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial. Diabetes Care. 2017 Apr;40(4):485-493. doi: 10.2337/dc16-2143. Epub 2017 Feb 10."
                    },
                    {
                        "pmid": "39963952",
                        "type": "DERIVED",
                        "citation": "Natale P, Green SC, Tunnicliffe DJ, Pellegrino G, Toyama T, Strippoli GF. Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2."
                    }
                ]
            }
        },
        "resultsSection": {
            "participantFlowModule": {
                "preAssignmentDetails": "A total of 426 participants underwent 4 week placebo run-in period. 436 participants were screen failures and 76 were run-in failures\u037e the most frequent reason for screen and run-in failure was glycosylated hemoglobin (HbA1c) criteria not met at end of the run-in phase. A total of 350 participants were randomized.",
                "recruitmentDetails": "The study was conducted at 83 centers in 13 countries. A total of 786 participants were screened between June 10, 2013 and July 09, 2014.",
                "groups": [
                    {
                        "id": "FG000",
                        "title": "Lixisenatide",
                        "description": "Lixisenatide 10 mcg subcutaneously once daily (QD) for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                    },
                    {
                        "id": "FG001",
                        "title": "Placebo",
                        "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                    }
                ],
                "periods": [
                    {
                        "title": "Overall Study",
                        "milestones": [
                            {
                                "type": "STARTED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "176"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "174"
                                    }
                                ]
                            },
                            {
                                "type": "COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "155"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "153"
                                    }
                                ]
                            },
                            {
                                "type": "NOT COMPLETED",
                                "achievements": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "21"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "21"
                                    }
                                ]
                            }
                        ],
                        "dropWithdraws": [
                            {
                                "type": "Adverse Event",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "15"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "10"
                                    }
                                ]
                            },
                            {
                                "type": "Lack of Efficacy",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "0"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "2"
                                    }
                                ]
                            },
                            {
                                "type": "Poor compliance to protocol",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "1"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "0"
                                    }
                                ]
                            },
                            {
                                "type": "Other than specified above",
                                "reasons": [
                                    {
                                        "groupId": "FG000",
                                        "numSubjects": "5"
                                    },
                                    {
                                        "groupId": "FG001",
                                        "numSubjects": "9"
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "baselineCharacteristicsModule": {
                "groups": [
                    {
                        "id": "BG000",
                        "title": "Lixisenatide",
                        "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                    },
                    {
                        "id": "BG001",
                        "title": "Placebo",
                        "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                    },
                    {
                        "id": "BG002",
                        "title": "Total",
                        "description": "Total of all reporting groups"
                    }
                ],
                "denoms": [
                    {
                        "units": "Participants",
                        "counts": [
                            {
                                "groupId": "BG000",
                                "value": "176"
                            },
                            {
                                "groupId": "BG001",
                                "value": "174"
                            },
                            {
                                "groupId": "BG002",
                                "value": "350"
                            }
                        ]
                    }
                ],
                "measures": [
                    {
                        "title": "Age, Continuous",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "years",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "74",
                                                "spread": "4"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "74.4",
                                                "spread": "3.8"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "74.2",
                                                "spread": "3.9"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Sex: Female, Male",
                        "paramType": "COUNT_OF_PARTICIPANTS",
                        "unitOfMeasure": "Participants",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "title": "Female",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "84"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "84"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "168"
                                            }
                                        ]
                                    },
                                    {
                                        "title": "Male",
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "92"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "90"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "182"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Race",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Caucasian/white",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "128"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "122"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "250"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Black",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "3"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "0"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "3"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Asian/Oriental",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "5"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "11"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "16"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Other",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "40"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "41"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "81"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Ethnicity",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "Hispanic",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "51"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "48"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "99"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Not Hispanic",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "125"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "126"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "251"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Number of Participants with Categorical BMI",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "participants",
                        "classes": [
                            {
                                "title": "<30 kg/m^2",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "102"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "96"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "198"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "\u226530 kg/m^2",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "74"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "78"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "152"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Body Mass Index (BMI)",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "kg/m^2",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "29.91",
                                                "spread": "3.7"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "30.09",
                                                "spread": "4.53"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "30.00",
                                                "spread": "4.13"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Body Weight",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "kg",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "80.81",
                                                "spread": "14.54"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "80.08",
                                                "spread": "16.76"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "80.45",
                                                "spread": "15.66"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "HbA1c",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "Percentage of HbA1c",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "8.04",
                                                "spread": "0.72"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "8.05",
                                                "spread": "0.69"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "8.04",
                                                "spread": "0.71"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Fasting Plasma Glucose (FPG)",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "mmol/L",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "8.83",
                                                "spread": "2.38"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "8.89",
                                                "spread": "2.26"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "8.86",
                                                "spread": "2.32"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "2-Hour Postprandial Plasma Glucose (PPG)",
                        "description": "347 participants (174 in lixisenatide arm and 173 in placebo arm) were included for PPG analysis.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "mmol/L",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "15.18",
                                                "spread": "3.78"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "14.87",
                                                "spread": "3.69"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "15.03",
                                                "spread": "3.74"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Glucose Excursion",
                        "description": "345 participants (173 in lixisenatide arm and 172 in placebo arm) were included for glucose excursion analysis.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "mmol/L",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "6.51",
                                                "spread": "3.15"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "6.02",
                                                "spread": "3.17"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "6.26",
                                                "spread": "3.16"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "7-Point Self-monitored Plasma Glucose (SMPG)",
                        "description": "333 participants (171 in lixisenatide arm and 162 in placebo arm) were included for 7 point SMPG analysis.",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "mmol/L",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "9.79",
                                                "spread": "2.02"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "9.97",
                                                "spread": "1.98"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "9.87",
                                                "spread": "2.00"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "title": "Duration of Diabetes",
                        "paramType": "MEAN",
                        "dispersionType": "STANDARD_DEVIATION",
                        "unitOfMeasure": "years",
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "BG000",
                                                "value": "13.63",
                                                "spread": "7.34"
                                            },
                                            {
                                                "groupId": "BG001",
                                                "value": "14.63",
                                                "spread": "7.87"
                                            },
                                            {
                                                "groupId": "BG002",
                                                "value": "14.13",
                                                "spread": "7.62"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "outcomeMeasuresModule": {
                "outcomeMeasures": [
                    {
                        "type": "PRIMARY",
                        "title": "Absolute Change in HbA1c From Baseline to Week 24",
                        "description": "Change in HbA1c was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using last on-treatment observation carried forward (LOCF). On-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to 14 days after the last dose of study drug. Here, number of participants analyzed=participants with baseline and at least one post-baseline HbA1c assessment during on-treatment period.",
                        "populationDescription": "Modified intent to treat (mITT) population: all randomized participants who received at least one dose of study drug\u037e and had both baseline and at least one post-baseline efficacy assessment, irrespective of compliance with study protocol/procedures.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "percentage of hemoglobin",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "172"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "172"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-0.57",
                                                "spread": "0.075"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "0.06",
                                                "spread": "0.072"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Analysis was performed using analysis of covariance (ANCOVA) model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, \u22658.0%), randomization strata of basal insulin use at screening, randomization strata of Week -1 glomerular filtration rate (eGFR) (\u226530 to \\<60, \u226560 ml/min/1.73 m\\^2), and country as fixed effects and baseline HbA1c value as a covariate.",
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "< 0.0001",
                                "pValueComment": "Threshold for significance at 0.05 level.",
                                "statisticalMethod": "ANCOVA",
                                "paramType": "Least Square (LS) Mean Difference",
                                "paramValue": "-0.64",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-0.81",
                                "ciUpperLimit": "-0.464",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.088",
                                "estimateComment": "Lixisenatide vs Placebo"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in 2-Hour PPG From Baseline to Week 24",
                        "description": "The 2-hour PPG test measured blood glucose 2 hours after eating a liquid standardized breakfast meal. Change in PPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants analyzed=participants with baseline and at least one post-baseline 2-hour PPG assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "mmol/L",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "147"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "144"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-5.12",
                                                "spread": "0.392"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.07",
                                                "spread": "0.393"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Analysis was performed using ANCOVA model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, \u22658.0%), randomization strata of basal insulin use at screening, randomization strata of Week -1 eGFR (\u226530 to \\<60, \u226560 ml/min/1.73 m\\^2), and country as fixed effects and baseline 2-hour PPG value as a covariate. Hierarchical testing procedure was used to control type I error at 0.05. Testing was then performed sequentially in the order the endpoints were reported.",
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "< 0.0001",
                                "pValueComment": "Threshold for significance at 0.05 level. Testing sequence continued only when previous endpoint was statistically significant at 0.05.",
                                "statisticalMethod": "ANCOVA",
                                "paramType": "LS Mean Difference",
                                "paramValue": "-5.05",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-5.96",
                                "ciUpperLimit": "-4.132",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.464",
                                "estimateComment": "Lixisenatide vs Placebo"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in Average 7-point SMPG Profiles From Baseline to Week 24",
                        "description": "Participants recorded a 7-point plasma glucose profile measured before and 2 hours after each meal and at bedtime three times in a week before baseline, before visit Week 12 and before visit week 26 and the average value across the profiles performed in the week a visit for the 7-time points was calculated. Change in average 7-point SMPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to the day of last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants analyzed=participants with baseline and at least one post-baseline 7-point SMPG assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "mmol/L",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "138"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "125"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-1.15",
                                                "spread": "0.186"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.19",
                                                "spread": "0.189"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Testing according to the hierarchical testing procedure (only performed if the previous endpoint was statistically significant). Analysis was performed using ANCOVA model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, \u22658.0%), randomization strata of basal insulin use at screening, randomization strata of Week -1 eGFR (\u226530 to \\<60, \u226560 ml/min/1.73 m\\^2), and country as fixed effects and baseline 7-point SMPG value as a covariate.",
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "< 0.0001",
                                "pValueComment": "Threshold for significance at 0.05 level.",
                                "statisticalMethod": "ANCOVA",
                                "paramType": "LS Mean Difference",
                                "paramValue": "-0.96",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-1.39",
                                "ciUpperLimit": "-0.527",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.219",
                                "estimateComment": "Lixisenatide vs Placebo"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in Body Weight From Baseline to Week 24",
                        "description": "Change in body weight was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. On-treatment period for this efficacy variable was defined as the time from the first dose of study drug up to 3 days after the last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants analyzed=participants with baseline and at least one post-baseline body weight assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "kg",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "174"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "173"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-1.47",
                                                "spread": "0.241"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.16",
                                                "spread": "0.228"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Testing according to the hierarchical testing procedure (only performed if the previous endpoint was statistically significant). Analysis was performed using ANCOVA model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, \u22658.0%), randomization strata of basal insulin use at screening, randomization strata of Week -1 eGFR (\u226530 to \\<60, \u226560 ml/min/1.73 m\\^2), and country as fixed effects and baseline body weight value as a covariate.",
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "< 0.0001",
                                "pValueComment": "Threshold for significance at 0.05 level.",
                                "statisticalMethod": "ANCOVA",
                                "paramType": "LS Mean Difference",
                                "paramValue": "-1.32",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-1.862",
                                "ciUpperLimit": "-0.769",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.278",
                                "estimateComment": "Lixisenatide vs Placebo"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in FPG From Baseline to Week 24",
                        "description": "Change in FPG was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to 1 day after the last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants analyzed=participants with baseline and at least one post-baseline FPG assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "mmol/L",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "171"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "168"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-0.3",
                                                "spread": "0.224"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "0.01",
                                                "spread": "0.218"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ],
                        "analyses": [
                            {
                                "groupIds": [
                                    "OG000",
                                    "OG001"
                                ],
                                "groupDescription": "Testing according to the hierarchical testing procedure (only performed if the previous endpoint was statistically significant). Analysis was performed using ANCOVA model with treatment groups, randomization strata of Week -1 HbA1c (\\<8.0, \u22658.0%), randomization strata of basal insulin use at screening, randomization strata of Week -1 eGFR (\u226530 to \\<60, \u226560 ml/min/1.73 m\\^2), and country as fixed effects and baseline FPG value as a covariate.",
                                "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                                "pValue": "0.2347",
                                "pValueComment": "Threshold for significance at 0.05 level.",
                                "statisticalMethod": "ANCOVA",
                                "paramType": "LS Mean Difference",
                                "paramValue": "-0.31",
                                "ciPctValue": "95",
                                "ciNumSides": "TWO_SIDED",
                                "ciLowerLimit": "-0.828",
                                "ciUpperLimit": "0.204",
                                "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                "dispersionValue": "0.262",
                                "estimateComment": "Lixisenatide vs Placebo"
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants Requiring Rescue Therapy During 24 Week Treatment Period",
                        "description": "Routine fasting SMPG and central laboratory FPG (and HbA1c after Week 12) values were used to determine the requirement of rescue medication. If fasting SMPG value exceeded the specified limit for 3 consecutive days, the central laboratory FPG (and HbA1c after Week 12) were performed. Threshold values - from baseline to Week 8: fasting SMPG/FPG \\>270 mg/dL (15.0 mmol/L), from Week 8 to Week 12: fasting SMPG/FPG \\>240 mg/dL (13.3 mmol/L), and from Week 12 to Week 24: fasting SMPG/FPG \\>200 mg/dL (11.1 mmol/L) or HbA1c \\>9%.",
                        "populationDescription": "mITT population.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "Baseline up to Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "175"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "173"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "2.9"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "10.4"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in Plasma Glucose Excursions From Baseline to Week 24",
                        "description": "Plasma glucose excursion = 2-hour PPG minus plasma glucose 30 minutes prior to the liquid standardized breakfast meal test, before study drug administration. Change in plasma glucose excursions were calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants=participants with baseline and at least one post-baseline plasma glucose excursion assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "mmol/L",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "145"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "143"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-4.71",
                                                "spread": "0.331"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-0.25",
                                                "spread": "0.331"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Change in Total Daily Basal Insulin Dose From Baseline to Week 24 (in Participants Who Took Basal Insulin as Background Therapy)",
                        "description": "Change in basal insulin dose was calculated by subtracting baseline value from Week 24 value. Missing data was imputed using LOCF. The on-treatment period for this efficacy variable was the time from the first dose of study drug up to the day of last dose of study drug.",
                        "populationDescription": "mITT population. Here, number of participants analyzed=participants with baseline and at least one post-baseline basal insulin dose assessment during on-treatment period.",
                        "reportingStatus": "POSTED",
                        "paramType": "LEAST_SQUARES_MEAN",
                        "dispersionType": "Standard Error",
                        "unitOfMeasure": "units",
                        "timeFrame": "Baseline, Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "54"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "55"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "-2.97",
                                                "spread": "1.145"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "-1.3",
                                                "spread": "1.076"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With Symptomatic and Severe Symptomatic Hypoglycemia",
                        "description": "Symptomatic hypoglycemia was an event with clinical symptoms that were considered to result from a hypoglycemic episode with an accompanying plasma glucose less than 60 mg/dL (3.3 mmol/L) or associated with prompt recovery after oral carbohydrate, intravenous glucose, or glucagon administration if no plasma glucose measurement was available. Severe symptomatic hypoglycemia was symptomatic hypoglycemia event in which the participant required the assistance of another person and was associated with either a plasma glucose level below 36 mg/dL (2.0 mmol/L) or prompt recovery after oral carbohydrate, intravenous glucose, or glucagon administration, if no plasma glucose measurement was available.",
                        "populationDescription": "Analysis was performed on safety population defined as all randomized participants who received any amount of study drug.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "First dose of study drug up to 3 days after the last dose administration (maximum of 171 days)",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "176"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "174"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "title": "Symptomatic hypoglycemia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "7.4"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "5.7"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "title": "Severe symptomatic hypoglycemia",
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "0.57"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "0"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With HbA1c Reduction >0.5% at Week 24 and Did Not Experienced Documented (Plasma Glucose <60 mg/dL) Symptomatic Hypoglycemia",
                        "description": "The on-treatment period for HbA1c assessment was defined as the time from the first dose of study drug up to 14 days after the last dose of study drug. The on-treatment period for symptomatic hypoglycemia assessment was defined as the time from the first dose of study drug up to 1 day after the last dose of study drug.",
                        "populationDescription": "mITT population. Participants without any post-baseline on-treatment value for HbA1c were counted as non-responders if they experienced at least one symptomatic hypoglycemia. Otherwise, they were counted as missing.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "Week 24",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "172"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "172"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "57.6"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "21.5"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "SECONDARY",
                        "title": "Percentage of Participants With Gastrointestinal Disorders",
                        "populationDescription": "Analysis was performed on safety population.",
                        "reportingStatus": "POSTED",
                        "paramType": "NUMBER",
                        "unitOfMeasure": "percentage of participants",
                        "timeFrame": "Up to Day 171",
                        "groups": [
                            {
                                "id": "OG000",
                                "title": "Lixisenatide",
                                "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg."
                            },
                            {
                                "id": "OG001",
                                "title": "Placebo",
                                "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks."
                            }
                        ],
                        "denoms": [
                            {
                                "units": "Participants",
                                "counts": [
                                    {
                                        "groupId": "OG000",
                                        "value": "176"
                                    },
                                    {
                                        "groupId": "OG001",
                                        "value": "174"
                                    }
                                ]
                            }
                        ],
                        "classes": [
                            {
                                "categories": [
                                    {
                                        "measurements": [
                                            {
                                                "groupId": "OG000",
                                                "value": "40.3"
                                            },
                                            {
                                                "groupId": "OG001",
                                                "value": "20.7"
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            "adverseEventsModule": {
                "frequencyThreshold": "5",
                "timeFrame": "All adverse events (AEs) were collected from signature of the informed consent form up to the final visit (Day 171) regardless of seriousness or relationship to investigational medicinal product (IMP).",
                "description": "Reported adverse events are treatment-emergent adverse events that is AEs that developed/worsened during the 'on treatment period' (time from the first dose of study drug up to 3 days after the last dose of study drug).",
                "eventGroups": [
                    {
                        "id": "EG000",
                        "title": "Lixisenatide",
                        "description": "Lixisenatide 10 mcg subcutaneously QD for 2 weeks post-randomization, then at a maintenance dose of 20 mcg QD up to Week 24. If the maintenance dose of 20 mcg was not tolerated, dose could be reduced to 10 mcg.(Median exposure: 169 days)",
                        "seriousNumAffected": 8,
                        "seriousNumAtRisk": 176,
                        "otherNumAffected": 89,
                        "otherNumAtRisk": 176
                    },
                    {
                        "id": "EG001",
                        "title": "Placebo",
                        "description": "Placebo (matched to lixisenatide) subcutaneously QD for 24 Weeks. (Median exposure: 169 days)",
                        "seriousNumAffected": 10,
                        "seriousNumAtRisk": 174,
                        "otherNumAffected": 58,
                        "otherNumAtRisk": 174
                    }
                ],
                "seriousEvents": [
                    {
                        "term": "Bronchitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Lentigo maligna",
                        "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Cerebrovascular accident",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Epilepsy",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Hypoglycaemic unconsciousness",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Loss of consciousness",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Transient ischaemic attack",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Acute myocardial infarction",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Angina unstable",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Bradycardia",
                        "organSystem": "Cardiac disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Aortic aneurysm",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Hypertensive crisis",
                        "organSystem": "Vascular disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Dyspnoea",
                        "organSystem": "Respiratory, thoracic and mediastinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Abdominal pain lower",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Pancreatitis",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Systemic lupus erythematosus",
                        "organSystem": "Musculoskeletal and connective tissue disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Renal failure acute",
                        "organSystem": "Renal and urinary disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Fatigue",
                        "organSystem": "General disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Fall",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Hip fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Skull fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Spinal compression fracture",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 0,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Traumatic intracranial haemorrhage",
                        "organSystem": "Injury, poisoning and procedural complications",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 1,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 0,
                                "numAtRisk": 174
                            }
                        ]
                    }
                ],
                "otherEvents": [
                    {
                        "term": "Diarrhoea",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 19,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 13,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Nausea",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 44,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 13,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Vomiting",
                        "organSystem": "Gastrointestinal disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 10,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 1,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Nasopharyngitis",
                        "organSystem": "Infections and infestations",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 15,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 22,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Hypoglycaemia",
                        "organSystem": "Metabolism and nutrition disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 30,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 18,
                                "numAtRisk": 174
                            }
                        ]
                    },
                    {
                        "term": "Headache",
                        "organSystem": "Nervous system disorders",
                        "sourceVocabulary": "MedDRA 17.1",
                        "assessmentType": "SYSTEMATIC_ASSESSMENT",
                        "stats": [
                            {
                                "groupId": "EG000",
                                "numAffected": 10,
                                "numAtRisk": 176
                            },
                            {
                                "groupId": "EG001",
                                "numAffected": 8,
                                "numAtRisk": 174
                            }
                        ]
                    }
                ]
            },
            "moreInfoModule": {
                "certainAgreement": {
                    "piSponsorEmployee": false,
                    "restrictionType": "OTHER",
                    "restrictiveAgreement": true,
                    "otherDetails": "If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights."
                },
                "pointOfContact": {
                    "title": "Trial Transparency Team",
                    "organization": "Sanofi",
                    "email": "Contact-US@sanofi.com"
                }
            }
        },
        "derivedSection": {
            "miscInfoModule": {
                "versionHolder": "2025-09-19"
            },
            "conditionBrowseModule": {
                "meshes": [
                    {
                        "id": "D003924",
                        "term": "Diabetes Mellitus, Type 2"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D003920",
                        "term": "Diabetes Mellitus"
                    },
                    {
                        "id": "D044882",
                        "term": "Glucose Metabolism Disorders"
                    },
                    {
                        "id": "D008659",
                        "term": "Metabolic Diseases"
                    },
                    {
                        "id": "D009750",
                        "term": "Nutritional and Metabolic Diseases"
                    },
                    {
                        "id": "D004700",
                        "term": "Endocrine System Diseases"
                    }
                ]
            },
            "interventionBrowseModule": {
                "meshes": [
                    {
                        "id": "C479460",
                        "term": "lixisenatide"
                    },
                    {
                        "id": "D058110",
                        "term": "Counterfeit Drugs"
                    }
                ],
                "ancestors": [
                    {
                        "id": "D000078742",
                        "term": "Substandard Drugs"
                    },
                    {
                        "id": "D004364",
                        "term": "Pharmaceutical Preparations"
                    }
                ]
            }
        },
        "hasResults": true
    }
]